- Interventional Pain
- 1
Transforaminal Lumbar and Thoracic Interventions and Ischemic Spinal Cord Injury
By Scott E. Glaser, MD, DABIPP; Rinoo Shah, MD, MBA
Purchase PDFTransforaminal Lumbar and Thoracic Interventions and Ischemic Spinal Cord Injury
- SCOTT E. GLASER, MD, DABIPPPresident, Pain Specialists of Greater Chicago, 7055 High Grove Boulevard, Burr Ridge, IL, 60527
- RINOO SHAH, MD, MBAProfessor and Director, Pain Management Fellowship, Department of Anesthesiology, LSU Health Science Center, Shreveport, LA
Purchase PDFTransforaminal epidural steroid injections have been shown to be associated with catastrophic neurologic complications secondary to spinal cord infarction. The reflexive, ad hoc response of practitioners to these injuries has been to recommend risk minimization strategies to prevent embolism of the injected particulate steroids and to use nonparticulate steroids. This focus on distal embolism as the sole or primary cause of catastrophic outcomes lacks conclusive supporting evidence and does not suffice to protect the patient from paraplegia as it fails to address the root cause of the complications. A root cause analysis of the procedure provides evidence that the injection technique itself—the “safe triangle”—creates a risk of arterial damage and sequelae leading to ischemia of the spinal cord. The evidence is strong that the only way to mitigate or eliminate the risk of paraplegia is to use a different technique to perform transforaminal injections: the Kambin triangle approach. This change in technique is the only definitive solution that addresses the root cause of these catastrophic sequelae associated with transforaminal epidural steroid injections.
Key Words: Artery of Adamkiewicz, ischemic spinal cord injury, Kambin triangle, safe triangle, transforaminal epidural injection
- 2
Burst Spinal Cord Stimulation: Introduction to a New Age in Neuromodulation
By Timothy R. Deer, MD; Jason E. Pope, MD; Eric T. Lee, MD; Corey W. Hunter, MD
Purchase PDFBurst Spinal Cord Stimulation: Introduction to a New Age in Neuromodulation
- TIMOTHY R. DEER, MD
- JASON E. POPE, MD
- ERIC T. LEE, MD
- COREY W. HUNTER, MD
Purchase PDFSpinal cord neuromodulation has been a long-established treatment option for those suffering from various types of chronic pain. This minimally invasive procedure provides the potential for long-term pain relief, reducing the burden of other types of therapy, such as medications. As with any medical treatment, some patients do not tolerate or respond well to the therapy. This fact has led to recent developments in the technology to improve the therapeutic efficacy. More specifically, in 2010, Dr. Dirk De Ritter described what is known as burst waveforms, which may result in better outcomes than traditional tonic stimulation, which is most commonly used in clinically. An understanding of the mechanism of neuromodulation and how these waveforms disrupt different targets in the pain pathway therefore represents a significant advancement in the world of interventional pain medicine. This evolution of treatment may improve the lives of those suffering from lifelong pain conditions and chronic pain states.
- 3
Vertebral Compression Fractures and Options for Treatment
By Magdalena Anitescu, MD, PhD; Annie Layno-Moses, MD
Purchase PDFVertebral Compression Fractures and Options for Treatment
- MAGDALENA ANITESCU, MD, PHD
- ANNIE LAYNO-MOSES, MD
Purchase PDFVertebral compression fracture, a condition that affects almost one quarter of women in the United States, often presents as unrelenting pain with even minor movement. The condition has a significant effect on the decrease in quality of life of patients affected. Prompt diagnosis and treatment are key in the management of this condition. Although a conservative regimen with back braces and analgesics is the first initial step, invasive procedures, such as kyphoplasty and vertebroplasty, may be employed earlier in cases with severe debilitating pain, which is often not improved by first-line treatment.
- 4
Neuraxial Anesthesia
- PEDRAM ALESHI, MDAssociate Professor, Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA
- ATISA BEIHAGHI BRITTON, MDDepartment of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA, Anesthesia Resident
Purchase PDFNeuraxial anesthesia refers to all forms of central blockade involving the spinal, epidural, and caudal spaces. This is achieved by the administration of local anesthetic solution into the cerebrospinal fluid or into the epidural space, where the spinal nerve roots exist. Neuraxial blockade has a wide range of applications, including surgical anesthesia, postoperative analgesia, chronic pain management, and anesthesia and analgesia for labor and delivery. It is considered to be one of the most effective methods of producing anesthesia and analgesia as it provides completely reversible loss of sensation in the desired area. By minimizing the amount of systemic medications that are needed for pain relief or by avoiding general anesthesia altogether, neuraxial blockade provides many advantages, including decreased respiratory depression and somnolence, increased functional ability, earlier ambulation, and earlier return of bowel function after surgery. However, the performance of neuraxial blockade is not without risk and therefore requires a well-trained anesthesia provider for safe and effective administration, monitoring, and management. A detailed understanding of neuraxial anesthesia allows for safer practice for the practitioner and more informed decision making for the patient.
- 5
Dorsal Root Ganglion Spinal Cord Stimulation: A Novel Target in an Exciting Time in Neuromodulation
By Timothy R. Deer, MD; Jason E. Pope, MD; Eric T. Lee, MD; Corey W. Hunter, MD
Purchase PDFDorsal Root Ganglion Spinal Cord Stimulation: A Novel Target in an Exciting Time in Neuromodulation
- TIMOTHY R. DEER, MD
- JASON E. POPE, MD
- ERIC T. LEE, MD
- COREY W. HUNTER, MD
Purchase PDFThe dorsal root ganglion (DRG) is a cluster of neurons located in the dorsal nerve root and is responsible for relaying sensory signals from the peripheral nervous system to the brain. Previously, the DRG was thought to be a purely supportive structure with no active role in chronic neuropathic pain; more recent evidence, however, suggests that the DRG is directly responsible for the development and even maintaining it. The concept of DRG stimulation is quite similar to traditional stimulation, with one very important difference: rather than placing leads over the posterior aspect of the cord to affect the dorsal columns, the leads are placed over the DRG(s), thus stimulating the cell bodies directly and modulating the pain at the source.
Key words: causalgia, complex regional pain syndrome, dorsal root ganglion, neuromodulation, reflex sympathetic dystrophy, spinal cord stimulation
- 6
Vertebral Augmentation
By Siddarth Thakur, MD; Daniel Rothstein, MD, MBA; Kent H Nouri, MD
Purchase PDFVertebral Augmentation
- SIDDARTH THAKUR, MD
- DANIEL ROTHSTEIN, MD, MBA
- KENT H NOURI, MD
Purchase PDFVertebral compression fractures are a prevalent and growing public health problem associated with significant morbidity and economic cost. Most commonly, they occur in osteoporotic patients but are also seen in patients with metastatic cancer and secondary to trauma. Appropriate and timely treatment is imperative. When conservative treatments are inadequate, minimally invasive techniques, such as vertebroplasty and kyphoplasty, can provide substantial pain relief, improve function, and enhance quality of life. For appropriate patient selection, a comprehensive evaluation is essential to confirm the presence of concordant pain. Both vertebroplasty and kyphoplasty are performed percutaneously under radiographic guidance, and cement is injected into the collapsed vertebral body to provide strength and stability. Awareness of early and late procedure-related complications is necessary for perioperative planning. Overall, vertebral augmentation is a safe and efficacious procedure for patients suffering from pain related to vertebral compression fractures.
This review contains 10 figures, 5 tables, and 74 references.
Key words: adjacent level fractures, axial low back pain, cement injection, cement leakage, kyphoplasty, osteoporosis, parapedicular, polymethylmethacrylate, spinal metastasis, transpedicular, vertebral augmentation, vertebral compression fracture, vertebroplasty
- 7
Peripheral Nerve Blocks for the Lower Extremity
By Candace Shavit, MD; Monica W. Harbell, MD
Purchase PDFPeripheral Nerve Blocks for the Lower Extremity
- CANDACE SHAVIT, MD
- MONICA W. HARBELL, MD
Purchase PDFLower extremity peripheral nerve blocks (PNBs) are often used for surgical anesthesia and postoperative pain management. The use of PNB provides improved analgesia, reduced opioid consumption, and improved patient satisfaction and can facilitate earlier rehabilitation and discharge. As the number of lower extremity total joint arthroplasties is projected to increase significantly, the role of peripheral nerve blocks can be expected to grow in similar fashion. With the growing number of procedures and the increasing focus on patient experience and expeditious hospital discharge, PNBs are increasingly recognized as a powerful tool to improve patient care and facilitate recovery after lower extremity surgery. We provide a basic review of regional anesthesia for lower extremity surgical procedures. The widespread availability of ultrasonography has improved the performance and efficacy of PNBs; thus, we focus on ultrasonography-guided procedures. In this review, we discuss pertinent lower extremity anatomy and sonoanatomy, indications, patient outcome measures, techniques, and complications of the most commonly used blocks.
This review contains 35 figures, 11 tables, 5 videos, and 103 references.
Key words: adductor canal block, analgesia, ankle block, clinical applications of peripheral nerve blocks, complications of peripheral nerve blocks, continuous peripheral nerve catheter, early ambulation, fascia iliaca compartment block, femoral nerve block, lower extremity nerve blocks, lower extremity regional anesthesia, lumbar plexus block, obturator nerve block, peripheral nerve block, peripheral nerve catheter, popliteal block, psoas compartment block, regional anesthesia, regional anesthesia techniques, saphenous nerve block, sciatic nerve block, ultrasonography guided
- 1
- Pain Related Disease States
- 1
Approach to the Patient Presenting With Chest Pain
- JOHN TOBIAS NAGURNEY, MD MPHPhysician and Research Director, Department of Emergency Medicine, Massachusetts General Hospital and Associate Professor of Emergency Medicine, Harvard Medical School, Boston, MA
Purchase PDFCaring for the emergency department patient with chest pain represents an important challenge to the emergency physician. Chest pain is the second most common presentation among all emergency department patients, accounting for approximately 6 million visits per year in the United States. Chest pain may represent a benign condition or a time-critical life threat; symptom overlap between benign and serious conditions can make an accurate chest pain diagnosis challenging. This review covers the pathophysiology, assessment, stabilization, diagnosis and treatment, and disposition and outcomes of chest pain. The figure shows an algorithm outlining the approach to the patient with chest pain. Tables list critical and noncritical diagnoses in patients presenting with chest pain: history, physical examination, and bedside testing; risk factors or associations for acute coronary syndrome, pulmonary embolism, and aortic dissection; characteristics of the chest pain story to diagnose acute coronary syndrome; ABCDEs of resuscitation for patients with unstable vital signs; critical and noncritical diagnoses in patients presenting with chest pain: history, diagnosis, and treatment; prevalence of pulmonary embolism in patients classified as low or high probability for this diagnosis by Wells score, modified Geneva score, and gestalt; commonly recognized pitfalls in the workup and diagnosis of chest pain in the emergency department; critical diagnoses in patients presenting with chest pain: history, disposition, and outcome; and summary of current recommendations.
This review contains 1 highly rendered figure, 11 tables, and 54 references.
Key words: acute coronary syndrome, acute myocardial infarction, anginal pain, aortic dissection, cardiac-related pain, chest pain, coronary artery disease, non–ST segment elevation myocardial infarction, pulmonary embolism, ST segment elevation myocardial infarction
- 2
Axial Neck Pain
- VIKRAM B PATEL, MD, FIPP, DABIPPDirector, Phoenix Interventional Center for Advanced Learning Algonquin, IL
Purchase PDFNeck pain is one of the most common symptoms that we see in patients presenting to a pain center for treatment. The complex nature of pain generated by various elements in the neck as well as their radiation patterns sometimes makes it difficult to diagnose and treat a patient’s pain. A proper diagnosis is important for providing optimal management of neck pain. Axial neck pain mainly refers to the pain generated by the osseous elements and the intervertebral disks in the vertebral column. Neurologic pain presents differently from axial pain, exhibiting different characteristics and radiation patterns. The following review discusses the causes of axial neck pain, diagnoses, and available treatments.
This review contains 7 figures, 4 tables, and 26 references.
Keywords: Neck pain, range of motion, whiplash, subluxation, cervical spine, facet joints
- 3
Lumbar Facet–mediated Pain
- VIKRAM B PATEL, MD, FIPP, DABIPPDirector, Phoenix Interventional Center for Advanced Learning Algonquin, IL
Purchase PDFLumbar or lower back pain is a very debilitating condition that affects almost one fifth of the adult population during a given year. Almost everyone walking on two feet is bound to suffer from some back pain during their lifetime. The health care burden for treating low back pain is enormous, especially if the lost work hours are combined with the amount used in diagnosing and treating low back pain. Lumbar facet (zygapophysial) joints are one of the major components involved in causing lower back pain. Diagnosing the pain generator is more of an art than a science. Combining various parameters in the patient’s history, physical examination, and diagnostic studies is not much different from solving a murder mystery. Although facet joint pain may be accompanied by other pain generators, that is, lumbar intervertebral disks, nerve roots, and vertebral bodies, once treated, the relief in pain is more helpful in performing proper rehabilitation and improving further deterioration in low back pain. Muscles are almost always painful due to myofascial pain syndrome that accompanies the facet joint–related pain. Treating one without addressing the other leads to failure in management and optimization of patient’s pain and function. Several treatments are available for treatment of facet joint–mediated pain, including steroid injections using a miniscule amount and radiofrequency ablation of the nerves supplying the facet joints (medial branches of the dorsal primary ramus of the lumbar nerve root). With proper diagnosis and treatment, a patient’s pain and function can be optimized to a level where it may not impact the day-to-day activities or even resumption of the patient’s routine job function. The following review describes the anatomy, pathophysiology, diagnosis, and treatment of lumbar facet joint–mediated pain.
Key words: facet joint pain, facet joint syndrome, low back pain, medial branch radiofrequency, spondylolisthesis
- 4
Patient With Lumbar Spondylosis and Diskogenic Pain
- JIANGUO CHENG, MD, PHD, FIPPProfessor of Anesthesiology of Case Western Reserve University Cleveland Clinic Lerner College of Medicine, Vice President for Scientific Affairs, American Academy of Pain Medicine, Director, Cleveland Clinic Pain Medicine Fellowship Program, Departments of Pain Management and Neurosciences, Cleveland Clinic Anesthesiology Institute and Lerner Research Institute, Cleveland, OH
Purchase PDFDiskogenic low back pain (LBP), defined as pain that originates from a damaged vertebral disk, is a common cause of LBP. It is characterized by a three-phase cascade of degeneration marked by dysfunction, instability, and stabilization. A distinct pathologic characteristic of the disks from patients with diskogenic LBP has been found to be the formation of the zones of vascularized granulation tissue, with extensive innervation extending from the outer layer of the annulus fibrosus into the nucleus pulposus along a torn fissure. In addition, there appears to be an association between microbial infection and symptomatic disk degeneration. Low-virulence microorganisms, in particular Propionibacterium acnes, might be causing a chronic low-grade infection in the lower intervertebral disks in some patients. The diagnosis of diskogenic pain is primarily based on clinical manifestations, physical examinations, imaging studies, and provocative diskography. Diskogenic pain should be differentiated from other axial back pain conditions, such as facet arthropathy, sacroiliac joint pain, myofascial strain and pain, vertebral compression fracture, and other, less common conditions. Treatment options should be tailored to individual needs. Early and gradual physical and behavioral therapies are encouraged. Pharmacologic therapy, composed primarily of analgesics, nonsteroidal antiinflammatory drugs, muscle relaxants, and antidepressants, may have modest positive effects. A subset of patients with Modic type I changes in magnetic resonance imaging may benefit antibiotic therapy directed at the infected disks by P. acnes and other low-virulence microorganisms. There is evidence that supports the use of epidural steroid injections and intradiskal injections (methylene blue, ozone, steroids) for diskogenic pain. Additional options include intradiskal biacuplasty, gray ramus communicans nerve blocks/radiofrequency ablation, and intradiskal stem cell injections for disk repair/regeneration, all of which have gained support in clinical trials. These treatment modalities have shown promise to provide equal or even better outcomes compared with surgical spinal fusion or total disk replacement with an artificial disk.
This review contains 2 figures, 12 tables and 153 references
Keywords: Lumbar spondylosis, low back pain, diskogenic pain, herniated disk, annulus fibrosus, nucleus pulposus, osteoarthritis
- 5
Bertolotti Syndrome
- JIANG WU, MDAssistant Professor, Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA
- JIANGUO CHENG, MD, PHD, FIPPProfessor of Anesthesiology of Case Western Reserve University Cleveland Clinic Lerner College of Medicine, Vice President for Scientific Affairs, American Academy of Pain Medicine, Director, Cleveland Clinic Pain Medicine Fellowship Program, Departments of Pain Management and Neurosciences, Cleveland Clinic Anesthesiology Institute and Lerner Research Institute, Cleveland, OH
Purchase PDFBertolotti syndrome is caused by a lumbosacral transitional vertebra, a congenital variation of the most caudal lumbar vertebra, characterized by an enlarged transverse process that articulates or fuses with the sacrum, ilium, or both. This syndrome accounts for 4.6 to 7% of cases of low back pain in adults and for more than 11% of patients with low back pain who are under 30 years old. The primary effect of lumbosacral transitional vertebra is reduced and asymmetrical motion between the transitional vertebra and the sacrum, resulting in early arthritic changes at pseudoarticulation; the secondary effect is the progressively compensatory modifications in the biomechanics of the mobile vertebral segments superior to the transitional vertebra related to restriction in rotation and bending motion at the lumbosacral articulation. Bertolotti syndrome should be considered in the differential diagnosis of low back pain. Clinical findings include low back pain in the midline or paramedian area that is reproduced with palpation along the base of the lumbosacral spine and near the posterosuperior iliac spine and aggravated by forward flexion, excessive extension, or lateralization of the back to the same side of the mega-apophysis. A plain x-ray is diagnostic; the extension-flexion lumbosacral radiographs in anteroposterior, lateral, and oblique views demonstrate lumbosacral transitional vertebra, with an enlarged unilateral or bilateral transverse process of the most distal lumbar vertebra, abnormally articulating with the ala of the sacrum and degenerative changes of the pseudarthrosis. Other imaging studies, such as computed tomography and magnetic resonance imaging of the lumbosacral spine and selective radiculography of the spinal nerve, could provide additional detailed anatomic information. Major differential diagnoses of Bertolotti syndrome include sacroiliac joint pain, myofascial pain, lumbar facet pain, lumbar disk herniation, compression fracture, and Baastrup disease/interspinous bursitis. These conditions are not mutually exclusive and, in fact, often coexist. A course of conservative management, including activity modification, medication management with nonsteroidal antiinflammatory drugs, muscle relaxants, and rehabilitative physical therapy, should be offered initially. Due to the multifactorial etiology of low back pain in patients with Bertolotti syndrome, procedures such as diagnostic intrapseudoarticular block for arthritis, medial branch block for facet arthropathy, diskography for diskogenic pain, and selective nerve roots block for radiculopathy can potentially help identify the primary and secondary origins of the pain. Surgical treatment of Bertolotti syndrome was only slightly better than conservative treatment and should only be used in very selective patients with disk pathology. To achieve long-term improvement by any of these therapeutic options, a continuing physical rehabilitation program is often needed.
Key words: Bertolotti syndrome, intrapseudoarticular block, transitional lumbosacral vertebra, transverse process
- 6
Baastrup Disease/interspinous Bursitis
By Jianguo Cheng, MD, PhD, FIPP; Jijun Xu, MD, PhD
Purchase PDFBaastrup Disease/interspinous Bursitis
- JIANGUO CHENG, MD, PHD, FIPPProfessor of Anesthesiology of Case Western Reserve University Cleveland Clinic Lerner College of Medicine, Vice President for Scientific Affairs, American Academy of Pain Medicine, Director, Cleveland Clinic Pain Medicine Fellowship Program, Departments of Pain Management and Neurosciences, Cleveland Clinic Anesthesiology Institute and Lerner Research Institute, Cleveland, OH
- JIJUN XU, MD, PHD
Purchase PDFBaastrup disease (BD), an uncommon back pain syndrome, is characterized by pathologic approximation of adjacent spinous processes on a sagittal plane image. BD occurs most commonly at the lumbar L4-L5 level and tends to be more common in the elderly. The etiology is not precisely known, but BD may develop secondary to chronic active inflammatory facet arthropathy, leading to interspinous osteophytes and approximation of the adjacent spinous processes. Clinically, BD should be considered in the differential diagnosis of back pain if there is (1) midline back pain reproduced with palpation of the spinous process and exacerbated by extension of the lumbar spine and (2) direct contact of adjacent spinous processes on the lateral view of a plain x-ray image. Magnetic resonance imaging is more sensitive in detecting interspinous inflammation and the formation of bursa and new bone. Major differential diagnoses of BD include proliferative hyperostosis of the lumbar spinous processes, degenerative disease of the spine, sclerotic bone metastases to the spine, and ankylosing spondylosis. BD can be managed initially with nonsteroidal antiinflammatory drugs, a short-term steroid dose pack, and physical therapy. Injection of a local anesthetic to the inflamed spinous process and associated interspinous ligaments may be diagnostic, and injection of a local anesthetic/corticosteroid combination may be therapeutic. Surgery is reserved for patients with refractory BD. Surgical options include interspinous process decompression devices and excision of the affected spinous processes.
- 7
Patients With Sacroiliac Joint Pain and Arthritis
- JIANGUO CHENG, MD, PHD, FIPPProfessor of Anesthesiology of Case Western Reserve University Cleveland Clinic Lerner College of Medicine, Vice President for Scientific Affairs, American Academy of Pain Medicine, Director, Cleveland Clinic Pain Medicine Fellowship Program, Departments of Pain Management and Neurosciences, Cleveland Clinic Anesthesiology Institute and Lerner Research Institute, Cleveland, OH
Purchase PDFChronic pain originating from the sacroiliac joint (SIJ) is common. Pathophysiology is often related to biomechanical derangement affecting the SIJ or traumatic, degenerative, arthritic, and idiopathic changes of the SIJ. Diagnosis of SIJ pain is suggested by typical patterns of distribution, pain characteristics, and a combination of provocative tests, confirmed by diagnostic block of the SIJ, and differentiated from several other causes of low back pain. Multimodal therapy includes educational, physical, pharmacologic, interventional, and surgical approaches and should be individualized. The efficacy and safety of radiofrequency denervation of the sacroiliac joint have been demonstrated in randomized controlled trials. Multiple modalities of radiofrequency treatment exist, and comparative effectiveness studies are required to determine the most efficacious and cost-effective treatment modality.
- 8
Patient With Chronic Abdominal Pain From Pancreatitis
- JIANGUO CHENG, MD, PHD, FIPPProfessor of Anesthesiology of Case Western Reserve University Cleveland Clinic Lerner College of Medicine, Vice President for Scientific Affairs, American Academy of Pain Medicine, Director, Cleveland Clinic Pain Medicine Fellowship Program, Departments of Pain Management and Neurosciences, Cleveland Clinic Anesthesiology Institute and Lerner Research Institute, Cleveland, OH
Purchase PDFEarly diagnosis of chronic pancreatitis is possible by combining clinical information with pancreatic function testing, endoscopic ultrasonography, histology, and traditional imaging techniques such as magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography (ERCP). Such an approach helps improve the sensitivity and specificity of these complementary modalities. Pain management of chronic pancreatitis involves multidisciplinary and multimodal approaches. Behavioral modifications such as alcohol cessation, nutritional optimization, and cognitive-behavioral therapy play a significant role for better long-term outcomes. Pharmacologic management is directed at relieving both psychological and physical symptoms, and combination pharmacotherapies are often needed to address pancreatic deficiency, abdominal pain, and psychological disorders. Interventional approaches to celiac plexus and splanchnic nerve blocks and denervation (radiofrequency ablation, endoscopic or surgical denervation) may provide significant and prolonged pain relief. Neuromodulation in the form of spinal cord stimulation is a viable option for long-term pain relief. Managing complications of chronic pancreatitis, such as gastrointestinal complications (peptic ulcer, bile duct stenosis), pseudocysts, malnutrition, depression, diabetes, and painful diabetic neuropathy, is an integral part of comprehensive treatment and requires close collaboration between members of a multidisciplinary team.
This review contains 1 figures, 2 tables and 64 references
Key words: behavioral modifications, celiac plexus, chronic abdominal pain, chronic pancreatitis, interventional therapy, pharmacologic modulation, splanchnic nerves, surgical intervention
- 9
Patient With Chronic Pelvic Pain From Endometriosis
By Jianguo Cheng, MD, PhD, FIPP; Yoon-Jeong Cho, MD
Purchase PDFPatient With Chronic Pelvic Pain From Endometriosis
- JIANGUO CHENG, MD, PHD, FIPPProfessor of Anesthesiology of Case Western Reserve University Cleveland Clinic Lerner College of Medicine, Vice President for Scientific Affairs, American Academy of Pain Medicine, Director, Cleveland Clinic Pain Medicine Fellowship Program, Departments of Pain Management and Neurosciences, Cleveland Clinic Anesthesiology Institute and Lerner Research Institute, Cleveland, OH
- YOON-JEONG CHO, MD
Purchase PDFEndometriosis, a chronic and progressive condition characterized by the presence of endometrial tissue outside the uterus, accounts for about one third of the cases of chronic pelvic pain in women. Pain in endometriosis may be due to nociceptive, inflammatory, and/or neuropathic mechanisms. The clinical presentation is often variable between patients, and diagnostic laparoscopy for visualization and biopsy of lesions is the gold standard for diagnosis. The treatment may consist of two elements: chronic pelvic pain itself as a diagnosis and endometriosis as a disease. Hormonal therapy is used to reduce the amount of estrogen and hence reduce symptoms such as pelvic pain and dysmenorrhea. In patients with severe endometriosis, surgical removal of lesions, adhesions, and cysts and restoration of pelvic anatomy may be preferred. Both hormonal and surgical treatments have been shown to be effective in decreasing pain symptoms associated with endometriosis. A variety of analgesics, including nonsteroidal antiinflammatory drugs, opioids, tricyclic antidepressants, dual reuptake inhibitors of serotonin and norepinephrine, and antiepileptic drugs, have been used to ameliorate pain in endometriosis, with varying degrees of success. In patients with persistent symptoms, interventional pain management procedures may be performed to target the visceral and somatic organs and their innervations. Infertility is the most common complication of endometriosis. Between 10 and 20% of women with endometriosis have recurrence of the disease regardless of the treatment they receive. The recurrence of pain may be due to remodeling of the central nervous system, the role of the reproductive tract in reactivating pain, and incomplete removal or recurrence of lesions.
This review contains 2 tables and 52 references
Key words:chronic abdominal pain, chronic pelvic pain, dyschezia, dysmenorrhea, dyspareunia, endometrioma, endometriosis, hormonal therapy, infertility, retrograde menstruation, visceral pain
- 10
Pediatric Pain and Postoperative Management
- ELIZABETH A.M. FROST, MDClinical Professor, Icahn School of Medicine at Mount Sinai, New York, NY
Purchase PDFBoth assessment and management of pain in children present challenges for perioperative physicians, including surgeons, anesthesiologists, intensivists, and pediatricians, among others. Several reports have indicated that pediatric pain is undertreated postoperatively compared with pain in adults, resulting in both severe physical consequences, such as the development of chronic pain and complex regional pain syndromes, and significant psychological distress, such as nightmares and reversal of learned behavior. Moreover, chronic pain in childhood has been shown to heighten the risk for mental health problems in adulthood. Children with chronic pain (n = 14,790) reported higher rates of lifetime anxiety disorders (21.1% versus 12.4%) and depressive disorders (24.5% vs 14.1%) as adults. Although many evidence-based practice guidelines for pain management in younger people have been developed, adherence is often less than complete.
The perioperative physician should be aware of barriers in pediatric pain management and be able to address them, thus improving pain management and patient outcome. Some of the problems in dealing with pediatric pain management include a realization of the controversies as to the age at which children feel pain, how pain can be assessed from the newborn to the adolescent, how the level of education and involvement of parents impact the situation, and a general knowledge of available pain treatments for the pediatric population.
Key words: complications, opioids, pediatrics, postoperative pain, regional techniques
- 11
Phantom Limb Pain
By George C Chang Chien, DO; Alexander Bautista , MD; Kenneth D. Candido, MD
Purchase PDFPhantom Limb Pain
- GEORGE C CHANG CHIEN, DOMedical Director, Pain Management, Ventura County Medical Center, Director, Center for Regenerative Medicine, University of Southern California, CA
- ALEXANDER BAUTISTA , MDAssistant Professor, Department of Anesthesiology and Pain Management, Oklahoma University Oklahoma City, OK
- KENNETH D. CANDIDO, MDProfessor, Clinical Anesthesiology-UIC, Chairman, Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, IL
Purchase PDFPhantom limb is a complex pain phenomenon that is perceived by patients after a limb has been amputated. Many patients have the persistent perception that the particular limb that was lost is still present. This phenomenon, which may be painful and nonpainful, may develop immediately after amputation or in years following the incident. This phenomenon should not be confused with residual limb pain, formerly described as “stump pain,” which is pain that resides in the residual limb attached to the body. Phantom limb pain (PLP) is described similarly to other neuropathic pain conditions as burning, gnawing, stabbing, pressure, aching, squeezing, and knifelike. PLP is associated with a myriad of symptoms and considered one of the most challenging chronic pain conditions. The underlying mechanism of this phenomenon can be supraspinal, spinal, and peripheral. PLP remains a very challenging condition to treat. The therapies are similar to those of any other neuropathic pain states. A multimodal approach that includes interventional therapy, pharmacotherapy, rehabilitation, surgery, and preemptive analgesia working together improves success.
Key words: Amputation, amputee, central sensitization, mirror therapy, neuropathic pain, phantom limb pain, residual limb pain
- 12
Fibromyalgia
- DANIEL JOSEPH CLAUW, MDProfessor of Anesthesiology, Medicine and Psychiatry, Director, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI
Purchase PDFClinicians often encounter individuals who present with pain that they cannot adequately explain based on the degree of damage or inflammation noted in peripheral tissues. This typically prompts an evaluation looking for a cause of the pain. If no cause is found, these individuals are often given a diagnostic label that merely connotes that the patient has chronic pain in a region of the body, without an underlying mechanistic cause. Fibromyalgia (FM) is merely the current term for widespread musculoskeletal pain for which no alternative cause can be identified. This review covers the epidemiology, etiology/genetics, pathophysiology and pathogenesis, diagnosis, differential diagnosis, treatment, and complications and prognosis of FM. Figures show underlying mechanisms that can cause chronic pain; an individual’s “set point” or “volume control setting” for pain as set by a variety of factors, including the levels of neurotransmitters that either facilitate pain or reduce pain transmission; the 2011 Fibromyalgia Survey Criteria; symptoms and syndromes frequently seen in individuals with FM; the distribution of the 2011 Fibromyalgia Survey scores in a large cohort of individuals undergoing joint replacement surgery; and an algorithm showing the importance of dually focused treatment for FM and other chronic pain conditions. Tables list clinical characteristics of centralized pain, pharmacologic therapies for FM, and nonpharmacologic therapies for FM.
This review contains 6 figures, 9 tables, and 78 references.
Keywords: Fibromyalgia, chronic low back pain, headache, temporomandibular joint disorder, gastrointestinal disorder, irritable bowel syndrome (IBS), nonulcer dyspepsia, or esophageal dysmotility, interstitial cystitis, chronic prostatitis, vulvodynia, vulvar vestibulitis, and endometriosis
- 13
The Patient With Complex Regional Pain Syndrome
By George C Chang Chien, DO; Charles A Odonkor, MD; Robert Norman Harden, MD
Purchase PDFThe Patient With Complex Regional Pain Syndrome
- GEORGE C CHANG CHIEN, DOMedical Director, Pain Management, Ventura County Medical Center, Director, Center for Regenerative Medicine, University of Southern California, CA
- CHARLES A ODONKOR, MDJohn Hopkins Medicine, Baltimore, MD
- ROBERT NORMAN HARDEN, MDProfessor Emeritus of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, IL
Purchase PDFComplex regional pain syndrome (CRPS) is a multisymptom syndrome involving aberrant pathophysiology of the peripheral, autonomic, and/or central nervous systems. The central feature is severe, often debilitating pain. This is accompanied by a collection of sensory, motor, autonomic, skin, and/or bone abnormalities. A key feature is allodynia, where otherwise innocuous stimulation will cause pain and hyperalgesia. The patient will present with varying degrees of pain, allodynia, hyperalgesia, swelling, and color and temperature changes. There are often changes in motor function, such as muscle stiffness or even involuntary movements. Regional osteopenia, changes to hair and nail growth, and dystrophic cutaneous changes may occur. The Budapest criteria have been twice validated and are used to diagnose CRPS. A patient-centric clinical approach is important in the treatment of CRPS. Key domains to be addressed in the management of CRPS include rehabilitation and pain management with adjunct psychological therapy. It is important that these interventions happen concurrently within the continuum of care. With the guidance of a physician, physical therapist, occupational therapist, and neuropsychologist, rehabilitative training programs are designed to address motor, sensory, and cognitive deficits.
Key Words: Budapest criteria, complex regional pain syndrome, reflex sympathetic dystrophy, sympathetically mediated pain
- 14
Complementary and Alternative Medicine: Is It Alternative or Mainstream for Managing Low Back Pain?
By Maunak V. Rana, MD; Deepti Agarwal, MD; Utchariya Anantamongkol, PhD, MD
Purchase PDFComplementary and Alternative Medicine: Is It Alternative or Mainstream for Managing Low Back Pain?
- MAUNAK V. RANA, MD
- DEEPTI AGARWAL, MD
- UTCHARIYA ANANTAMONGKOL, PHD, MD
Purchase PDFAlthough long an integral part of the health systems of societies all around the globe, the role of complementary and alternative medicine (CAM) in Western medicine has become better defined over the past few years, especially in multidisciplinary pain management. Many patients have expressed dissatisfaction at conventional treatments of therapy, medications, and procedures. Often they have sought adjunctive treatments to make up for deficits in efficacy and to minimize unwanted side effects. CAM has been a source to fill the void. Additionally, physical modalities that promote the mind-body connection in pain states have emerged in common practice. Of the physical modalities helpful in the concurrent management of pain, yoga has emerged as one of the most effective options. The medical literature has identified acupuncture as efficacious and safe and determined that it may have benefit as a sole therapy or in conjunction with traditional interventions. Although nutraceuticals and marijuana have received lay press exposure and interest, as pain therapeutics, the mechanism of action of these agents needs to be more precisely elucidated and regulatory bodies need to ensure quality control and dosage safety in society.
This review contains 4 figures, 1 table and 118 references
Key Words: acupuncture, lower back pain (LBP), medical marijuana, nutraceuticals, transcutaneous electrical nerve stimulation (TENS)
- 15
Pain in the Spinal Cord–injured Patient
- CHIRAG D. SHAH, MD, JD
- MAUNAK V. RANA, MD
Purchase PDFManagement of pain in the spinal cord–injured patient can be a stressful and difficult challenge for both the patient and the physician. In spinal cord injury (SCI), pain can occur immediately or months later, with the potential for persistent pain throughout a lifetime. Unfortunately, pain in this population is often overshadowed or minimized. This is often due to bigger concerns of physical immobility, medical comorbidities, and functional capacity. Achieving pain control leads to a higher likelihood of patients regaining independence in their activities of daily living (ADL), along with providing biopsychosocial benefits to them and their contacts. Using a classification system based on injury acuity, location, and characterized pain state to identify pain generators can help practitioners implement targeted treatment plans. A combination of interventional, physical, pharmacologic, and psychological treatment will help attack the interminable issues that develop along the life span of a patient after injury. Promptly starting treatment will improve our successful management of SCI pain with care that is preventive rather than reactionary.
- 16
Patients With Hearing Impairment and Chronic Pain
By Alan D. Kaye, MD, PhD; Sudipta Sen, MD ; Elyse Cornett, PhD; Charles Fox, MD
Purchase PDFPatients With Hearing Impairment and Chronic Pain
- ALAN D. KAYE, MD, PHDProfessor, Program Director, and Chairman, Department of Anesthesiology, Professor, Department of Pharmacology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LAV
- SUDIPTA SEN, MD Assistant Professor, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- ELYSE CORNETT, PHDClinical Research Coordinator, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- CHARLES FOX, MDProfessor and Chairman, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
Purchase PDFDeaf patients face unique obstacles in health care and pain management. Not every facility that deaf patients encounter is going to have the proper resources to effectively communicate with them even if regulations are mandated. The Americans with Disabilities Act (ADA) requires that health care institutions provide means of communication for patients, their family members, and hospital visitors who are deaf or hard of hearing. Very little research has been done regarding how the hearing-impaired population effectively communicates pain experiences. Hearing loss can be accompanied by an additional disability, which can further complicate communication between health care providers and deaf patients. Although resources are available to aid communication between health care practitioners and deaf individuals, resources related to hearing loss plus additional disabilities and health care are lacking. Health care providers should educate themselves and their staff so that they are prepared to treat a deaf patient and accommodate the patient’s communication needs.
- 17
Patients With Pain During Pregnancy
By Charles J. Fox, MD, FACS; Alan D. Kaye, MD, PhD; Elyse Cornett, PhD; Katherine Stammen, MD; Michael Franklin, DO
Purchase PDFPatients With Pain During Pregnancy
- CHARLES J. FOX, MD, FACSAssociate Professor of Surgery, University of Colorado School of Medicine, Chief of Vascular Surgery, Department of Surgery, Denver Health Medical Center, Denver, CO
- ALAN D. KAYE, MD, PHDProfessor, Program Director, and Chairman, Department of Anesthesiology, Professor, Department of Pharmacology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LAV
- ELYSE CORNETT, PHDClinical Research Coordinator, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- KATHERINE STAMMEN, MD
- MICHAEL FRANKLIN, DO
Purchase PDFMost women experience some degree of pain during pregnancy. Back painoccurs in about half of all pregnant women, with pain typically in the low back due to the physiologic changes in the body that occur with pregnancy, such as weight gain, changed center of gravity, increased ligament and joint laxity, and altered posture. Pelvic pain, leg cramps, and abdominal pain are all common among pregnant women.Many women who have pain during pregnancy are reluctant to use analgesics due to concerns about what the medications may do to their unborn child. Because of this, it is hypothesized that many women are either undertreated for pain or do not receive any treatment. Chronic, severe pain that is ineffectively treated is associated with hypertension, anxiety, and depression, all of which do not lead to a healthy pregnancy.A variety of interventional procedures are commonly performed during pregnancy that can safely alleviate pain. This review goes into detail about the types of pain treatments that are available to pregnant women and are safe and effective in alleviating pregnancy-related pain.
Keywords: Pelvic pain, leg cramps, abdominal pain, hypertension, anxiety, depression, joint laxity, ligament laxity, back pain, analgesics, pregnancy
- 18
Patients in the Postpartum and Breast-feeding Period
By Charles J. Fox, MD, FACS; Alan D. Kaye, MD, PhD; Sudipta Sen, MD ; Elyse Cornett, PhD; Debbie Chandler, MD
Purchase PDFPatients in the Postpartum and Breast-feeding Period
- CHARLES J. FOX, MD, FACSAssociate Professor of Surgery, University of Colorado School of Medicine, Chief of Vascular Surgery, Department of Surgery, Denver Health Medical Center, Denver, CO
- ALAN D. KAYE, MD, PHDProfessor, Program Director, and Chairman, Department of Anesthesiology, Professor, Department of Pharmacology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LAV
- SUDIPTA SEN, MD Assistant Professor, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- ELYSE CORNETT, PHDClinical Research Coordinator, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- DEBBIE CHANDLER, MD
Purchase PDFPain after childbirth is common. The incidence of chronic postpartum pain is rising and has been shown to have a negative impact on the mother, the baby, and the rest of the family. Estrogen heightens pain sensitivity in women, and high levels of estrogen are normally seen during pregnancy. In patients who have had a cesarean section, postpartum pain can be caused by several different factors, including pain at the point of incision, infection at the incision site, suture breakdown, tape burn, or collection of fluid under the skin. In addition to complications during a cesarean section, other complications can arise during childbirth that require the use of pain medications, and this can cause concern for mothers who are breast-feeding. This review outlines the types of complications that can occur in mothers after the delivery of a baby and the types of medications they are prescribed. Additionally, this review outlines which drugs are safe for the breast-feeding mother and baby as well as medications that should be used with caution.
- 19
Patients With Metastatic Breast Cancer Who Had Radical Mastectomy Complicated by Lymphedema
By Charles J. Fox, MD, FACS; Alan D. Kaye, MD, PhD; Elyse Cornett, PhD; Veerandra Koyyalamudi, MD; Terin Thompkins, MD
Purchase PDFPatients With Metastatic Breast Cancer Who Had Radical Mastectomy Complicated by Lymphedema
- CHARLES J. FOX, MD, FACSAssociate Professor of Surgery, University of Colorado School of Medicine, Chief of Vascular Surgery, Department of Surgery, Denver Health Medical Center, Denver, CO
- ALAN D. KAYE, MD, PHDProfessor, Program Director, and Chairman, Department of Anesthesiology, Professor, Department of Pharmacology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LAV
- ELYSE CORNETT, PHDClinical Research Coordinator, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- VEERANDRA KOYYALAMUDI, MDAssistant Professor, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- TERIN THOMPKINS, MDSenior Resident, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
Purchase PDFThe past few decades have seen a shift in breast cancer surgery to a more conservative approach from radical mastectomy to breast-conserving therapy and from axillary node dissection to minimally invasive sentinel node biopsy. The adoption of more conservative surgical approaches was taken with the aim of reducing morbidity after surgery and improving long-term functional capacity. This review outlines complications that can arise in treating breast cancer and the therapies that can be used to treat patients with these conditions.
This review contains 3 tables and 47 references.
Key words: breast cancer, biopsy, chemotherapy, endocrine therapy, lymphedema, lymphatic drainage, mastectomy, radiotherapy
- 20
Patient Presents With Pancreatic Cancer
By Alan D. Kaye, MD, PhD; Elyse Cornett, PhD; Charles Fox, MD; Rinoo Shah, MD, MBA; Sailesh Arulkumar, MD; Kevin K. Bradley, MD; Hany Rayan, MD; Raisa Pinto, MD
Purchase PDFPatient Presents With Pancreatic Cancer
- ALAN D. KAYE, MD, PHDProfessor, Program Director, and Chairman, Department of Anesthesiology, Professor, Department of Pharmacology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LAV
- ELYSE CORNETT, PHDClinical Research Coordinator, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- CHARLES FOX, MDProfessor and Chairman, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- RINOO SHAH, MD, MBAProfessor and Director, Pain Management Fellowship, Department of Anesthesiology, LSU Health Science Center, Shreveport, LA
- SAILESH ARULKUMAR, MD
- KEVIN K. BRADLEY, MD
- HANY RAYAN, MD
- RAISA PINTO, MD
Purchase PDFCancer pain is complex and challenging to treat. Pancreatic cancer pain occurs in 75% of patients and over 90% of patients in advanced stages. Pain management should be individual to the patient and involve a multidisciplinary approach. No one treatment modality has been found to be effective in alleviating pancreatic cancer pain; therefore, all treatment options should be considered. Opioids are a cornerstone of cancer pain management; however, the neurolytic celiac plexus block can be a useful treatment modality in pancreatic cancer patients. This review discusses the types of pain that are seen in pancreatic cancer patients and how to treat that pain through a multimodal, multidisciplinary approach.
This review contains 3 figures and 28 references.
- 21
Patient With an Ankle Sprain
- ANDREA TRESCOT, MD, ABIPP, FIPP
Purchase PDFAnkle sprains are a very common injury, suffered by approximately 25,000 patients per year, and affect all age groups, including children, athletes, and the elderly. The recognition of the type of ankle sprain (medial, lateral, syndesmotic) affects early and late management of ankle sprains. Also discussed are the acute diagnosis and treatment of ankle sprains, as well as the consequences of chronic ankle instability, which may include serious conditions such as complex regional pain syndrome and chronic ankle instability. Surgical and nonsurgical treatment, evaluation, prognosis, and prevention are also discussed.
Key words:ankle pain, ankle sprain, chronic ankle instability, complex regional pain syndrome, cryoneuroablation, high ankle sprain, lateral ankle sprain, medial ankle sprain,
- 22
Perioperative Management of the Surgical Patient on Suboxone (buprenorphine and Naloxone)
By Vimal N. Desai, MD; Jane C Ahn, MD; Kyle S Ahn, MD
Purchase PDFPerioperative Management of the Surgical Patient on Suboxone (buprenorphine and Naloxone)
- VIMAL N. DESAI, MDClinical Instructor, Department of Anesthesiology & Perioperative Care, University of California, Irvine, Orange, CA
- JANE C AHN, MDAssociate Clinical Professor, Department of Anesthesiology & Perioperative Care, University of California, Irvine, Orange, CA
- KYLE S AHN, MDAssociate Clinical Professor, Department of Anesthesiology & Perioperative Care, University of California, Irvine, Orange, CA
Purchase PDFOver the past two decades, the incidence of legal and illegal drug abuse and dependency has increased at alarming levels, resulting in a rise in the number of associated deaths. Multiple resources are available to manage addiction, including the use of buprenorphine with or without naloxone. Consequently, more and more patients are requiring this treatment and are presenting for elective and emergent surgery where treatment of acute postoperative pain in the setting of buprenorphine use becomes challenging due to its unique properties. Buprenorphine has unique properties in which it binds to the opioid (mu) receptor with a higher affinity than other opioids. Buprenorphine is bound for a long period of time (32 hours), but its opioid effects have a ceiling. Since the receptors are occupied, when illegal or prescribed opioids are abused, they cannot activate the occupied receptors, and, in parallel, the effects that lead to addiction, tolerance, and craving are limited. However, in the surgical setting, increased opioid use may be appropriately needed to manage pain, which is hindered and limited by buprenorphine. Using current studies and strategies, we propose an algorithm to effectively manage buprenorphine in the perioperative setting.
- 23
Hematologic Cancer Pain
By John Blackburn, MD; Ankit Patel, MD; Nabil Aounallah, MD; Alex Bautista, MD
Purchase PDFHematologic Cancer Pain
- JOHN BLACKBURN, MDPain Medicine Fellow, Department of Anesthesiology, The University of Oklahoma College of Medicine Oklahoma City, OK
- ANKIT PATEL, MDAnesthesiology Resident, Department of Anesthesiology, The University of Oklahoma College of Medicine, Oklahoma City, OK
- NABIL AOUNALLAH, MDAnesthesiology Resident, Department of Anesthesiology, The University of Oklahoma College of Medicine, Oklahoma City, OK
- ALEX BAUTISTA, MDAssistant Professor, Department of Anesthesiology, The University of Oklahoma College of Medicine, Oklahoma City, OK
Purchase PDFHematologic cancers represent about 10% of new cancer diagnoses annually in the United States and account for a comparable number of US cancer deaths each year. These patients experience an array of acute and chronic pain syndromes that appreciably impair their quality of life. The pathogenesis, management, and complications of multiple myeloma, lymphoma, and leukemia are reviewed to provide a better understanding of the underlying pain processes. Skeletal-related events due to bony involvement, including pain, pathologic fractures, hypercalcemia, and spinal cord compression, along with renal insufficiency, represent a significant portion of complications faced by multiple myeloma patients. Opioids continue to be the foundation of cancer analgesia in accordance with the World Health Organization three-step analgesic ladder. Many of the long-term complications in lymphoma patients are due to treatment with toxic chemotherapy regimens along with radiation. Many of the complications seen in leukemia are nonspecific and common to cancer and its treatment in general. Bone pain is common for a number of reasons in leukemia, typically manifesting as a throbbing deep and dull ache. An array of pain syndromes develop from diagnosis through cancer survival that command a multifaceted management approach.
This review contains 7 tables, 3 figures and 40 references.
- 24
Complex Regional Pain Syndrome: the Worst Pain Known to Humankind
By Pradeep Chopra, MD
Purchase PDFComplex Regional Pain Syndrome: the Worst Pain Known to Humankind
- PRADEEP CHOPRA, MD
Purchase PDFComplex regional pain syndrome (CRPS) is the worst pain known to humankind. It has been classified as pain worse than cancer pain, amputation of a digit, or labor pain. The difference is that CRPS is a chronic condition that lasts for many years. As in all medical conditions, the essential piece to diagnosis of CRPS is based on the clinical history and physical examination. The diagnosis of CRPS depends on the following: pain, color and temperature asymmetry, swelling, and nail and hair growth changes. The intensity of the pain is far more than expected from the inciting injury and in some cases from immobilization. The pain spreads to a wider area than the original site. It may spread to the opposite side and even to the whole body, including the viscera. The pain is unrelated to any physical activity but does increase significantly with using the body part. A color differential between the affected and the unaffected side is often very obvious but may not be present continuously. A temperature differential of 1.1ºC between the affected and the unaffected side is considered significant. The color and temperature differential is not as obvious in the torso or the axial skeleton as in CRPS of the abdomen, perineum, or chest wall. The swelling is much more evident in the initial stages of the condition and can vary from a small area of pitting edema to large diffuse swelling to the point of skin becoming thin and glossy and even breaking down. Hair changes may consist of darker, coarser hair or light and sparse hair. Nails may be brittle, discolored, and ridged. There is no gold standard test to diagnose CRPS. Testing may be done to rule out another possible diagnosis.
- 25
Connective Tissue Disorders: Ehlers-danlos Syndrome
- PRADEEP CHOPRA, MD
Purchase PDFAlmost every physician is bound to come across patients with connective tissue disorders, especially Ehlers-Danlos syndrome (EDS). These patients present with a cluster of conditions, including chronic joint, muscle, and neuropathic pain; easy fractures; gastrointestinal symptoms; orthostatic intolerance; headaches; spinal pain; urinary symptoms; recurrent joint subluxations and dislocations; and aneurysm. The incidence of EDS is 10 in 100,000. These patients have a genetic defect in their collagen. A weak connective tissue makes the joints hypermobile, causes muscle fatigue, easy bruising, fragile skin, spinal pain, and headaches. The diagnosis is made clinically based on a medical history and clinical examination. It does not depend on genetic testing. The Beighton score has been the most widely accepted for diagnosing EDS. It has proven to be a very consistent screening tool. The most common symptom patients present with is pain. They have increased pain at different stages of their life; as adolescents, they have growing pains. These pains are usually worse during periods of growth spurt. The pain is intense and usually in the lower extremity around the knees, and they have leg cramps, especially at night. Concerned parents are told to ignore it, and no specific treatment is offered to these children. As adults, patients present with a more specific pain to either a region or the spine. Musculoskeletal pain is most commonly around the neck, upper back, hips, legs, and forearms. In most cases, the pain is around the weight-bearing muscles, such as the legs and spine. Patients with EDS present with both nociceptive (structural) and neuropathic pain; in some cases, the neuropathic pain component may be more prominent than the nociceptive component and vice versa. One of the major issues in EDS is a loss of proprioception, also known as joint position sense. Proprioception is the ability of a joint to determine its position, detect movement, and sense resistance to force. EDS is associated with other coexisting conditions, such as postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), Chiari malformation, and tethered cord syndrome. Significant fatigue is a common feature in EDS. The reason for fatigue may be an abnormality of the muscle structure, POTS, MCAS, and excessive dependence on muscles to maintain posture in light of ligamentous laxity.
- 26
Arthritis of the Knee
By Vandana Sharma, MD; Kevin Anuvat, MD; Liju John, MD; Matthew Davis, MD
Purchase PDFArthritis of the Knee
- VANDANA SHARMA, MDAssistant Professor of Anesthesiology, Department of Anesthesiology and Pain Treatment, Upstate Medical University, Syracuse NY.
- KEVIN ANUVAT, MDPain Management Fellow, Department of Anesthesiology and Pain Treatment, Upstate Medical University, Syracuse NY.
- LIJU JOHN, MDDepartment of Physical Medicine & Rehabilitation, Upstate Medical University, Syracuse NY.
- MATTHEW DAVIS, MDDepartment of Physical Medicine & Rehabilitation, Upstate Medical University, Syracuse NY.
Purchase PDFOsteoarthritis (OA) of the knee is the most common form of degenerative joint disease, affecting 13.9% of adults age 25 years and older and 33.6% of those 65 years and older. Some predisposing risk factors include age, obesity, infection, repetitive use, occupation, and previous trauma. Mild OA usually presents as pain in the knee with difficulty bending or straightening the knee, swelling, weakness, instability, locking, and clicking or snapping of the knee. A diagnosis can be made clinically and confirmed by x-ray showing narrowing of the joint space in mild cases; however, bone changes, subchondral cysts, and formation of bony spurs can be seen in more advanced stages. Treatment of mild to moderate OA involves a multimodal approach that includes lifestyle modifications, physical therapy, and electrical stimulation with or without pharmacologic management. Interventional therapies such as intra-articular corticosteroid injections and viscosupplementation are usually reserved for severe symptoms. Pharmacologic modalities such as acetaminophen, nonsteroidal antiinflammatory drugs, weak opioids, and duloxetine can be used as a single agent or combination therapy. Novel approaches to the treatment of OA include nerve growth factor inhibitors, botulinum toxin type B injections, and intra-articular platelet-rich plasma but are not well supported due to a lack of sufficient evidence.
Key words: arthritis, degenerative joint disease of the knee, diagnosis, etiology, guidelines, noninflammatory arthritis, osteoarthritis of the knee, treatment
- 27
Patient With Thoracic (spinal) Pain
By Jianguo Cheng, MD, PhD, FIPP; Yoon-Jeong Cho, MD
Purchase PDFPatient With Thoracic (spinal) Pain
- JIANGUO CHENG, MD, PHD, FIPPProfessor of Anesthesiology of Case Western Reserve University Cleveland Clinic Lerner College of Medicine, Vice President for Scientific Affairs, American Academy of Pain Medicine, Director, Cleveland Clinic Pain Medicine Fellowship Program, Departments of Pain Management and Neurosciences, Cleveland Clinic Anesthesiology Institute and Lerner Research Institute, Cleveland, OH
- YOON-JEONG CHO, MD
Purchase PDFAlthough less common than cervical or lumbar pain, thoracic pain is not an uncommon presentation in pain clinics. Thoracic pain may be nociceptive, neuropathic, mixed, or idiopathic. It can originate from bony structures, facet joints, intervertebral disks, or muscles and fascia. In addition, pain from the diaphragm, cervical spine, chest, and abdominal viscera may be referred to the thoracic region. Some of the conditions that should be kept in the differential include ankylosing spondylitis, Tietze syndrome, costochondritis, diffuse idiopathic skeletal hyperostosis, Scheuermann kyphosis, thoracolumbar junction syndrome, osteoarthritis, rheumatoid arthritis, vertebral compression fractures, facet arthropathy, and primary cancer and metastatic disease of the spine. This review focuses on thoracic pain of spinal and musculoskeletal origin. However, it is imperative not to overlook visceral pain because it may be associated with a life-threatening condition.
Key words: ankylosing spondylitis, costochondritis, diffuse idiopathic skeletal hyperostosis, Maigne syndrome, sacroiliitis, Scheuermann kyphosis, slipping rib syndrome, thoracolumbar junction syndrome, Tietze syndrome
- 28
Cervical Radiculopathy
- ROBERT B BOLASH, MD
- PAVAN TANKHA, DO
Purchase PDFCervical radiculopathy refers to injury or compression to the cervical nerve root(s) that results in pain and/or numbness distribution of the nerve. Clinically, patients present with neck and/or arm pain and numbness in the concordant dermatomes or myotomes. In the absence of “red flag” symptoms, treatment consists of conservative, medical, and interventional therapies. This review covers the epidemiology and etiology, pathophysiology and pathogenesis, diagnosis, treatment, and prognosis of cervical radiculopathy. The figure shows the cervical vertebrae and associated neural elements. Tables list the “red flag” symptoms suggesting prompt evaluation, clinical correlates among patients with cervical radiculopathy, and the differential diagnosis of cervical radiculopathy.
This review contains 1 figure, 3 tables, and 36 references
Key words: C7 nerve root, cervical nerve compression, cervical nerve injury, cervical nerve root, cervical radiculopathy, cervical spondylosis, neck pain
- 29
Lumbar Spinal Stenosis and Neurogenic Claudication
By Laxmaiah Manchikanti, MD; Sheri L Albers, DO; Richard Latchaw, MD
Purchase PDFLumbar Spinal Stenosis and Neurogenic Claudication
- LAXMAIAH MANCHIKANTI, MD
- SHERI L ALBERS, DO
- RICHARD LATCHAW, MD
Purchase PDFLumbar spinal stenosis is a degenerative condition that develops and progresses slowly over time. Lumbar spinal stenosis may be local, segmental, or generalized. The majority of lumbar spinal stenosis cases are acquired, degenerative stenosis, resulting from aging of the spine or following surgery or infection. Management of lumbar spinal stenosis is challenging and requires the integration of the history, clinical findings, and results of diagnostic imaging. Magnetic resonance imaging is the most commonly used imaging modality in diagnosing lumbar spinal stenosis. Typical features of spinal stenosis with neurogenic claudication include an increase in symptoms with extension and a decrease with flexion. With lateral recess stenosis or foraminal stenosis, isolated radiculopathy can occur. Spinal stenosis is classified as mild, moderate, and severe, ranging from one third to two thirds of the canal, and grade I to grade III classification of neurogenic intermittent claudication. Management of lumbar spinal stenosis is largely conservative except in cases of severe spinal stenosis and neurogenic claudication with or without paresis and other symptoms. Nonsurgical management of lumbar spinal stenosis includes drugs, physiotherapy, epidural injections, multidisciplinary rehabilitation, and spinal cord stimulation. Minimally invasive techniques include minimally invasive lumbar spinal decompression, interspinous spacers, and endoscopic surgical decompression. The final treatments include open surgery with decompression with or without fusion and spinal cord stimulation.
Key words: acquired stenosis, central spinal stenosis, congenital stenosis, decompression with fusion, decompression without fusion, endoscopic spinal decompression, epidural injections, foraminal spinal stenosis, interspinous spacers, lateral spinal stenosis, lumbar spinal stenosis, minimally invasive lumbar decompression, neurogenic claudication, percutaneous adhesiolysis, shopping cart syndrome, spondylolisthesis, vascular claudication
- 30
Lumbar Disk Herniation
By Laxmaiah Manchikanti, MD; Sheri L Albers, DO; Joshua A Hirsch, MD; Mark V Boswell, MD, PhD
Purchase PDFLumbar Disk Herniation
- LAXMAIAH MANCHIKANTI, MD
- SHERI L ALBERS, DO
- JOSHUA A HIRSCH, MD
- MARK V BOSWELL, MD, PHD
- 31
Patient With Postthoracotomy Pain
By Jianguo Cheng, MD, PhD, FIPP; Olivia T Cheng, MD Candidate
Purchase PDFPatient With Postthoracotomy Pain
- JIANGUO CHENG, MD, PHD, FIPPProfessor of Anesthesiology of Case Western Reserve University Cleveland Clinic Lerner College of Medicine, Vice President for Scientific Affairs, American Academy of Pain Medicine, Director, Cleveland Clinic Pain Medicine Fellowship Program, Departments of Pain Management and Neurosciences, Cleveland Clinic Anesthesiology Institute and Lerner Research Institute, Cleveland, OH
- OLIVIA T CHENG, MD CANDIDATECase Western Reserve University School of Medicine, Cleveland, OH
Purchase PDFPain due to thoracotomy is among the most severe pain experienced after surgery. It has both neuropathic and myofascial components. About 50% of patients suffer from chronic postthoracotomy pain 1 year after surgery. Thoracic paravertebral block or thoracic epidural analgesia is recommended as the first-choice therapy for thoracotomy analgesia. Preoperatively initiated thoracic epidural analgesia is associated with better pain control and decreased incidence (and intensity) of chronic postthoracotomy pain compared with postoperative (epidural or intravenous) analgesia. Compared with inhalation anesthesia, total intravenous anesthesia significantly reduced the incidence of chronic postthoracotomy pain syndrome, which is notoriously challenging to treat. Gabapentinoids and antidepressants may be beneficial for the neuropathic component of chronic postthoracotomy pain syndrome. A pregabalin and methylcobalamin combination has been shown to be safe and effective in the treatment of chronic postthoracotomy pain, with minimal side effects. Interventional therapies such as intercostal nerve block or ablation, spinal cord stimulation, and targeted subcutaneous neuromodulation may be indicated in more refractory and debilitating cases.
This review contains 1 table, and 57 references.
Key words: chronic postthoracotomy pain, cryoneurolysis, intercostal nerve block, open thoracotomy surgery, paravertebral block, postthoracotomy pain, postthoracotomy pain syndrome, spinal cord stimulation, thoracic epidural analgesia, thoracotomy, total intravenous analgesia, video-assisted thoracoscopic surgery
- 32
Axial Neck Pain
- VIKRAM B PATEL, MD, FIPP, DABIPPDirector, Phoenix Interventional Center for Advanced Learning Algonquin, IL
- 33
- 34
Patient With Lumbar Spondylosis and Diskogenic Pain
- JIANGUO CHENG, MD, PHD, FIPPProfessor of Anesthesiology of Case Western Reserve University Cleveland Clinic Lerner College of Medicine, Vice President for Scientific Affairs, American Academy of Pain Medicine, Director, Cleveland Clinic Pain Medicine Fellowship Program, Departments of Pain Management and Neurosciences, Cleveland Clinic Anesthesiology Institute and Lerner Research Institute, Cleveland, OH
- 1
- Headache and Neurological Disorders
- 1
Head and Neck Blocks for Headache and Facial Pain
By Yury Khelemsky, MD; Adham Zayed, MD
Purchase PDFHead and Neck Blocks for Headache and Facial Pain
- YURY KHELEMSKY, MD
- ADHAM ZAYED, MD
Purchase PDFSince medications and interventions may not yield adequate efficacy for many patients with headache and facial pain, the management of these complex conditions often requires a multidisciplinary and multimodal effort. As part of a multifaceted approach, different procedures may have utility in alleviating pain for a variety of pathologies. This article reviews practical considerations for performing occipital nerve blocks, trigeminal nerve blocks, cervical medial branch blocks, cervical epidural steroid injections, sphenopalatine ganglion blocks, and trigger-point injections. Although there is growing evidence for the utility of these varied procedures, further research is warranted to clearly define which patient groups may derive the greatest benefit from these interventions, as well as optimal approaches to enhance their effectiveness.
Most recent advances covered (3-5):
1. Greater occipital blocks performed with lesser occipital blocks are a useful therapy to complement conservative management to reduce length, frequency, and duration of migraine headache.
2. Cervical medial branch blocks may be helpful for not only for neck pain, but for headache, however, more research is needed in this area.
3. Although dry needling is effective for myofascial pain, injection of local anesthesia may provide longer lasting relief.
- 2
Postherpetic Neuralgia: A Patient’s and a Physician’s Perspective
By James H. Diaz, MD, MHA, MPH, DrPH, FACA, DABA, FACPM
Purchase PDFPostherpetic Neuralgia: A Patient’s and a Physician’s Perspective
- JAMES H. DIAZ, MD, MHA, MPH, DRPH, FACA, DABA, FACPM
Purchase PDFHerpes zoster can plague anyone who has had varicella or has received the varicella or chickenpox vaccine. The incidence of herpes zoster increases with age and rises exponentially after 60 years of age. Postherpetic neuralgia (PHN) may occur after herpes zoster at any age but typically occurs after 50 years of age, with over 40% of persons over 60 years of age suffering from PHN after a shingles attack. Up to 1 million new cases of herpes zoster and 200,000 new cases of PHN may now be anticipated in the United States every year, with the incidence rate increasing as the population grows and ages with prolonged life expectancies. Although new antiviral medications will improve and shorten the course of herpes zoster, they do not guarantee the prevention of PHN. Given the high prevalence of PHN in an aging population and the availability of primary prevention by vaccination, the objectives of this review are to describe the epidemiology, pathophysiology, and clinical manifestations of zoster and PHN and to recommend a combination of strategies for the clinical management and prevention of PHN.
This review contains 6 figures, 6 tables and 15 references
Keywords: evidence-based pain medicine, herpes zoster, neuropathic pain, postherpetic neuralgia
- 3
Tension-type Headache: Epidemiology, Diagnosis, and Pathophysiology
By Paul Rizzoli, MD, FAAN, FAHS
Purchase PDFTension-type Headache: Epidemiology, Diagnosis, and Pathophysiology
- PAUL RIZZOLI, MD, FAAN, FAHSAssistant Professor of Neurology, Harvard Medical School, Clinical and Fellowship Director John R. Graham Headache Center, Brigham and Women’s Faulkner Hospital, Boston, MA
Purchase PDFTension-type headache (TTH) is a significant but underappreciated condition that is much more frequent than migraine, 42% versus 11%, and produces significant socioeconomic burden. Why then do research advances in this condition seem to lag?
One reason is that precise epidemiologic data are lacking, with lifetime prevalence estimates varying from about 13 to 78%. Also, classification is confounded by whether or not to include the occasional but universal headache as TTH. Furthermore, TTH pathophysiology is debated, with some feeling that the pathophysiology of TTH is similar to and on a spectrum with migraine, and some feeling that it is entirely separate and related to peripheral and muscular mechanisms. More recently, central pain mechanisms have also been implicated in the pathophysiology. In addition, a large body of information connects stress and TTH.
Although TTH varies widely in frequency and severity among and within patients, TTH pain, compared with pain in other headache types, could be characterized generally as more mild in severity and more generalized in location. This review discusses the current epidemiologic data and diagnostic challenges in TTH and the current pathophysiologic mechanisms.
- 4
Neuropathic Pain
By Nantthasorn Zinboonyahgoon, MD; Sherif Al-Hawarey, MD; Grace Chen, MD
Purchase PDFNeuropathic Pain
- NANTTHASORN ZINBOONYAHGOON, MD
- SHERIF AL-HAWAREY, MD
- GRACE CHEN, MD
Purchase PDFNeuropathic pain is a common but complex condition. The pathophysiology and mechanisms are not fully understood. The evaluation should incorporate a detailed history and physical examination with the selective investigations. There is still no standard classification of neuropathic pain; however, it may be classified as central or peripheral or by location and etiology. The common etiologies of neuropathic pain include diabetes mellitus, chemotherapy, alcohol, inflammation, and HIV. Since neuropathic pain is a chronic condition and unlikely to be cured or to disappear, the goal of treatment includes pain control as well as improved physical functions, attenuated psychological distress, and improved quality of life. The team approach by integrating pharmacologic treatment, physical therapy, pain psychology, and complementary medicine would improve the patient’s quality of life and outcome.
Key words: classification, diagnosis, etiology, neuropathic pain, treatment
- 5
Pediatric Headache Disorders
- MARC T DISABELLA, DOAssistant professor of child neurology at The George Washington School of Medicine and Health Sciences, and director of pediatric headache at the Center for Neurosciences and Behavioral Health, Children’s National Medical Center, Washington, DC
- RAQUEL LANGDON, MDInstructor of child neurology at The George Washington School of Medicine and Health Sciences and co-director of Pediatric Headache and Concussion at the Center for Neurosciences and Behavioral Health, Children’s National Medical Center, Washington, DC
Purchase PDFHeadache is the most common neurologic disorder in the population, and most children will experience headaches recurrently throughout childhood and adolescence. Current estimates suggest that one in four children and adolescents experience migraine, one of the most severe forms of headache. It is imperative to differentiate primary headache disorders, including migraine and tension-type headache, from secondary headaches, including posttraumatic and medication overuse headache, to successfully diagnose and manage symptoms. Headache results in significant disability in children, including significant social stigma, school absenteeism, and avoidance of normal activities (eg, athletic and social activities). Headache can be successfully managed by providing patients and their families with a variety of techniques, including healthy lifestyle habits, cognitive-behavioral therapy, selected medications in the appropriate setting, and possibly complementary therapies, which may include acupuncture, physical therapy, and nutraceuticals.
This review contains 1 figure, 16 tables, and 40 reference.
Key words: Headache, migraine, concussion, lifestyle modification, tension-type headache, secondary headache, neuroimaging
- 6
Migraine: Psychiatric Comorbidities
By Todd A Smitherman, PhD; Anna Katherine Black, MA; A Brooke Walters Pellegrino, PhD
Purchase PDFMigraine: Psychiatric Comorbidities
- TODD A SMITHERMAN, PHDAssociate Professor of Psychology, Department of Psychology, University of Mississippi, Oxford, MS
- ANNA KATHERINE BLACK, MAGraduate Student, Clinical Psychology, Department of Psychology, University of Mississippi, Oxford, MS
- A BROOKE WALTERS PELLEGRINO, PHDDirector of Behavioral Medicine, Hartford Healthcare Headache Center, West Hartford, CT
Purchase PDFPsychiatric disorders often co-occur with migraine, and these comorbid conditions compound disability and are risk factors for medication overuse and migraine progression. For these reasons, attention to psychiatric comorbidities in clinical practice is of paramount importance. Assessment of depression, anxiety, and sleep disorders is recommended, focusing on the core cognitive and emotional symptoms of the comorbidities and using measures validated among medical patients. Pharmacologic treatment of migraine and comorbid psychiatric conditions is challenging owing to a lack of agents with proven efficacy for both conditions, side effect profiles that may exacerbate one condition, and potential drug interactions. Existing data suggest that migraineurs with psychiatric symptomatology can obtain positive outcomes with appropriate preventive medications, behavioral interventions for headache or the comorbid condition, or a combination thereof.
Keywords: anxiety, comorbidity, depression, insomnia, migraine, pharmacotherapy, relaxation, stress management
- 7
Difficult to Treat (refractory) Chronic Migraine: Outpatient Approaches
By Lawrence Robbins, MD, (retired)
Purchase PDFDifficult to Treat (refractory) Chronic Migraine: Outpatient Approaches
- LAWRENCE ROBBINS, MD, (RETIRED) Assistant Professor of Neurology, Dept. of Neurology, University of Illinois; (retired) Assistant Professor of Neurology, Dept. of Neurology, Rush Medical College, Chicago, Il
Purchase PDFThis comprehensive review addresses the many challenges in treating refractory migraine. Issues relating to pathophysiology are covered. A unique “refractory scale for migraine patients” is introduced. The definition and role of medication overuse headache are presented with a much different perspective than is usually found. Issues outside of medication that are covered include active coping, acceptance, resilience, and catastrophizing. A number of outpatient treatments are thoroughly discussed. These include the role of onabotulinum toxin, the application of polypharmacy, when to employ sphenopalatine ganglion blocks, the role of occipital and trigger-point injections, the implementation of long-acting opioids, the advantages of stimulants, and the possible use of monoamine oxidase inhibitors. Miscellaneous approaches include muscle relaxants, nasal or intravenous ketamine, transcranial magnetic stimulation, memantine, and ergonovine. Finally, many cutting-edge “refractory clinical pearls” are listed.
This review contains 8 highly rendered figures, 4 tables, and 25 references.
Key Words: Headache, migraine, chronic, refractory, medication overuse, alternative, treatments
- 8
Nerve Blocks and Neurostimulation in the Treatment of Migraine
By Matthew S Robbins, MD
Purchase PDFNerve Blocks and Neurostimulation in the Treatment of Migraine
- MATTHEW S ROBBINS, MDAssociate Professor of Clinical Neurology, Albert Einstein College of Medicine, Chief of Neurology, Jack D. Weiler Hospital, Montefiore Medical Center, Director of Inpatient Services, Montefiore Headache Center, Associate Program Director, Neurology Residency, Bronx, NY
Purchase PDFPeripheral nerve and sphenopalatine ganglion blocks are a safe, effective treatment option for headache disorders, although, despite a wealth of anecdotal experience, the evidence is conflicting for efficacy in chronic migraine prophylaxis. Neurostimulation has emerged as an effective treatment modality for migraine with both noninvasive and minimally invasive options available. Such options include transcutaneous supraorbital nerve stimulation for prophylaxis and single-pulse transcranial magnetic stimulation for the acute treatment of migraine with aura. Although occipital nerve stimulation may be effective for some patients with intractable chronic migraine, the evidence is mixed and procedure-related complications are common. Emerging treatment modalities for acute and preventive treatment of migraine include noninvasive vagus nerve stimulation and implanted sphenopalatine ganglion stimulation.
This review contains 5 figures, 7 tables, and 108 references
Keywords: headache, migraine, neurostimulation, nerve block, pain
- 9
Tension-type Headache: Acute and Preventive Therapies
- MELISSA RAYHILL, MDAssistant Professor, Department of Neurology, University at Buffalo School of Medicine, the State University of New York at Buffalo
Purchase PDFTension-type headache (TTH) is an incredibly common condition. The clinician should be careful to distinguish TTH from migraine and from causes of secondary headache. The importance of regular sleep, nutrition, hydration, and appropriate management of life stressors cannot be overemphasized. The mainstays of abortive pharmacologic therapy for TTH are the nonsteroidal antiinflammatory drugs. Most of these drugs are thought to have roughly equivalent efficacies based on many older clinical trials and more recent meta-analyses. The side effects of this drug class can be severe and include renal toxicity and gastrointestinal bleeding; these drugs may also increase cardiovascular risk. Tricyclic antidepressants are thought to be the most effective preventive therapy for TTH, particularly amitriptyline. Other antidepressant medications as well as muscle relaxants may also be beneficial in some patients. A number of other nonpharmacologic and procedural therapies exist, although the evidence supporting the use of these treatments is variable. However, in many patients, these other modalities can be helpful therapeutic adjuncts. In this review, we also discuss the evidence base for physical therapy, acupuncture, trigger-point injections, massage therapy, and psychological therapy.
- 10
Migraine: Behavioral Treatment
- ELIZABETH K SENG, PHDAssistant Professor, Ferkauf Graduate School of Psychology, Yeshiva University, New York, NY
Purchase PDFBehavior change is an essential component of any migraine management plan. Behavioral migraine treatments are interventions designed to change a patient’s behavior with the result of a reduction in migraine symptoms and migraine-related disability. Behavioral treatments commonly target medication adherence, behavioral and psychosocial factors known to precipitate migraine (including stress, sleep, and skipping meals), maladaptive cognitive patterns, and comorbid psychiatric symptoms (most commonly depression and anxiety). Guidelines and evidence from randomized clinical trials indicate that biofeedback, relaxation treatments, and cognitive-behavioral therapy are effective preventive migraine treatments. Patient education and self-monitoring are foundational components to any behavioral intervention for migraine. Portable personal technology is increasingly becoming an essential part of migraine patient care and provides another avenue for supporting adherence to medication and behavioral migraine management.
This review contains 6 figures, 10 tables, and 52 references.
Key words: Anxiety; behavior; biofeedback; cognitive-behavioral therapy; depression; migraine; psychology; relaxation; sleep; stress; breathing exercises
- 11
Migraine Epidemiology, Impact, and Pathogenesis
- AMY A GELFAND, MDDirector, Pediatric Headache, Division of Child Neurology, Department of Neurology, UCSF Benioff Children’s Hospital, San Francisco, CA
- DAWN C BUSE, PHDAssociate Professor, Department of Neurology, Albert Einstein College of Medicine of Yeshiva University, Assistant Professor, Clinical Health Psychology Doctoral Program, Ferkauf Graduate School of Psychology of Yeshiva University, Director of Behavioral Medicine, Montefiore Headache Center Bronx, NY
Purchase PDFMigraine is a common and often disabling neurologic disorder. No longer thought of as neurovascular in etiology, migraine is now known to be a complex disorder of the brain with strong genetic underpinnings. The impact of migraine may extend beyond the affected individual to also impact partners and children. Although many patients search to identify “triggers” of migraine, teasing out such relationships can be remarkably complex. The premonitory phase of a migraine attacks can include symptoms such as food cravings, photophobia, and increased yawning—symptoms that could, for example, lead a person to mistakenly conclude that the migraine attacks are “triggered” by eating chocolate, bright lights, or being tired. We review current evidence on the epidemiology, impact, and pathophysiology of migraine.
This review contains 9 tables, and 94 references.
Key words: Epidemiology, impact, migraine, pathophysiology, socioeconomic status, gender
- 12
Pediatric Headache Disorders
- MARC T DISABELLA, DOAssistant professor of child neurology at The George Washington School of Medicine and Health Sciences, and director of pediatric headache at the Center for Neurosciences and Behavioral Health, Children’s National Medical Center, Washington, DC
- RAQUEL LANGDON, MDInstructor of child neurology at The George Washington School of Medicine and Health Sciences and co-director of Pediatric Headache and Concussion at the Center for Neurosciences and Behavioral Health, Children’s National Medical Center, Washington, DC
- 13
Migraine: Behavioral Treatment
- ELIZABETH K SENG, PHDAssistant Professor, Ferkauf Graduate School of Psychology, Yeshiva University, New York, NY
- 14
Migraine Epidemiology, Impact, and Pathogenesis - High Yield
By Amy A Gelfand, MD; Dawn C Buse, PhD
Purchase PDFMigraine Epidemiology, Impact, and Pathogenesis - High Yield
- AMY A GELFAND, MDDirector, Pediatric Headache, Division of Child Neurology, Department of Neurology, UCSF Benioff Children’s Hospital, San Francisco, CA
- DAWN C BUSE, PHDAssociate Professor, Department of Neurology, Albert Einstein College of Medicine of Yeshiva University, Assistant Professor, Clinical Health Psychology Doctoral Program, Ferkauf Graduate School of Psychology of Yeshiva University, Director of Behavioral Medicine, Montefiore Headache Center Bronx, NY
- 15
Postherpetic Neuralgia: A Patient’s and a Physician’s Perspective
By James H. Diaz, MD, MHA, MPH, DrPH, FACA, DABA, FACPM
Purchase PDFPostherpetic Neuralgia: A Patient’s and a Physician’s Perspective
- JAMES H. DIAZ, MD, MHA, MPH, DRPH, FACA, DABA, FACPM
- 16
Nerve Blocks and Neurostimulation in the Treatment of Migraine
By Matthew S Robbins, MD
Purchase PDFNerve Blocks and Neurostimulation in the Treatment of Migraine
- MATTHEW S ROBBINS, MDAssociate Professor of Clinical Neurology, Albert Einstein College of Medicine, Chief of Neurology, Jack D. Weiler Hospital, Montefiore Medical Center, Director of Inpatient Services, Montefiore Headache Center, Associate Program Director, Neurology Residency, Bronx, NY
- 1
- Special Topics
- 1
Opioid Therapy for Chronic Noncancer Pain: Safe, Effective, Appropriate?
By Joseph V. Pergolizzi Jr, MD; Robert B. Raffa, PhD, Professor Emeritus; Robert Taylor, PhD; Jo Ann LeQuang, BA
Purchase PDFOpioid Therapy for Chronic Noncancer Pain: Safe, Effective, Appropriate?
- JOSEPH V. PERGOLIZZI JR, MDNEMA Research, Inc., Naples, FL
- ROBERT B. RAFFA, PHD, PROFESSOR EMERITUSDepartment of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA Adjunct Professor, Department of Pharmacology and Toxicology, University of Arizona College of Pharmacy
- ROBERT TAYLOR, PHDExecutive Director of Operations, NEMA Research, Inc., Bonita Springs, FL
- JO ANN LEQUANG, BADirector of Scientific Communications, NEMA Research, Inc., Bonita Springs, FL
Purchase PDFIn determining the appropriate role of opioids, two public health crises must be balanced: the opioid abuse epidemic and the “silent” crisis of unrelieved chronic pain. Opioids can be used safely and effectively in selected patients; however, clinicians must be aware of their abuse liability and individual risk factors for opioid misuse. A number of opioids are approved for use in the United States, and although there are class effects, there can be great variability among patients with regard to opioid response. In addition to the medication, prescribers must also determine the most appropriate dose and route of administration. Considerations must be made for special population, such as the renally impaired, those with hepatic dysfunction, and pediatric and elderly patients. Another factor is abuse-deterrent properties. Of particular interest as an opioid agent is buprenorphine, which is available in various routes of administration and because of its unique pharmacokinetics may be administered to renally compromised and elderly patients without dosing restrictions. Buprenorphine is also associated with a lower abuse liability than other opioids. Patients suffering moderate to severe pain syndromes should not be denied access to effective pain control, which in some cases may appropriately include opioid therapy.
Key words:Buprenorphine, Chronic Pain, Opioid, Opioid Abuse, Opioid Prescribing, Risk Factors for Opioid Abuse
- 2
Physicians' Role in Curbing the Worst Drug Crisis in America: Prescription Opioid Abuse
By Sairam Atluri, MD, FIPP; Gururau Sudarshan, MD, FRCA
Purchase PDFPhysicians' Role in Curbing the Worst Drug Crisis in America: Prescription Opioid Abuse
- SAIRAM ATLURI, MD, FIPPDirector, Tristate Pain Management Institute, Cincinnati, OH
- GURURAU SUDARSHAN, MD, FRCADirector, Cincinnati Pain Physicians, Cincinnati, OH
Purchase PDFOpioids have an important role in the management of acute, cancer, and chronic pain. However, their indiscriminate use in chronic pain has led, in part, to the epidemic of prescription drug abuse, resulting in a dramatic increase in morbidity and mortality in America. Most of this abuse originates from legitimate prescriptions by physicians. Prescribing opioids to chronic pain patients while restricting them to those who abuse them is very challenging, and physicians seek appropriate and unbiased prescribing guidelines. Our review, based on analysis of the available literature, focuses on striking a balance between overprescribing and underprescribing. The core concept of this strategy relies in using screening tools to identify patients who are at high risk for opioid abuse along with diligent monitoring using prescription monitoring programs and urine drug screens, while also limiting opioid doses. Hopefully, using these principles, physicians can more confidently prescribe opioids to those who would benefit from these powerful drugs and at the same time keep opioids away from those who could potentially be harmed.
This review contains 3 figures, 4 tables, and 98 references.
Key Words: abuse, addiction, chronic pain, dose limitation, misuse, monitoring, opioids, overdose, screening
- 3
Pain and Chemical Dependency
- SANFORD M SILVERMAN, MDCEO and Medical Director, Comprehensive Pain Medicine, Pompano Beach, FL, Affiliate Assistant Professor of Clinical Biomedical Science, Department of Integrated Medical Sciences, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL
Purchase PDFPain can mean different things to different people. At the same time, it is a subjective and objective sensation. For the patient experiencing pain, it is an unpleasant sensation that causes undue suffering. Chemical dependency or addiction is characterized by inability to consistently abstain, impairment in behavioral control, and craving; diminished recognition of significant problems with one’s behaviors and interpersonal relationships; and a dysfunctional emotional response. It is a complex chronic disease of brain reward, motivation, memory, and related circuitry. The prevailing view of opioid therapy for chronic pain is a pendulum swinging between opiophobia and opiophilia. The intersection between pain and addiction is also a moving target. Various stakeholders have attempted to find a balance between addressing the crisis of chronic pain in society and not exacerbating the problem of substance abuse. The pain practitioner must recognize the duality that exists between chronic and chemical dependency and must assess risk prior to using controlled substances to manage that pain, and if things go awry, the physician must have an exit strategy. Discharging problem patients merely transfers the problem elsewhere. Offering patients a solution to iatrogenic dependence on controlled substances is a viable and compassionate path for both the patient and the practitioner.
This review contains 2 figures, 2 tables, and 20 references.
Key Words: pain, opioids, opiophobia, opiophilia, substance abuse, chemical dependency, addiction, chronic pain
- 4
Serotonin Syndrome
- RAVI MIRPURI, DOChief Resident, Department of Physical Medicine and Rehabilitation University of California, Irvine, Orange, CA
- DANIELLE PERRET KARIMI, MDAssociate Dean, Graduate Medical Education, Associate Physician, Department of Physical Medicine and Rehabilitation, University of California, Irvine, Orange, CA
Purchase PDFSerotonin syndrome (SS) is a complication that occurs due to drug interactions that result in an increase in serotonin in the central nervous system. This syndrome is classically described as a triad of altered mental status, autonomic hyperactivity, and neuromuscular abnormalities that can be life threatening. As such, prompt detection is crucial so that treatment can be delivered to prevent long-term complications from hyperthermia, malignant hypertension, and/or cardiac arrhythmias. Determining the diagnosis can be difficult as several other conditions have similarities to SS; these include malignant hyperthermia, neuroleptic malignant syndrome, and anticholinergic toxicity. If appropriately managed, SS typically resolves within 24 hours once all serotoninergic medications are discontinued. If inappropriately prescribed, serotoninergic drugs such as antibiotics, analgesics, supplements, or antidepressants may all contribute toward inducing this preventable syndrome, if given in excess. This comprehensive review of SS provides the clinician with a detailed understanding of the pathogenesis, diagnosis, and treatment of this complex disease state.
This review contains 5 tables and 26 references
Keywords: Serotonin syndrome, altered mental status, hyperactivity, hyperthermia, neuromucular disorder, antidepressants
- 5
Pain in the Intensive Care Setting
- BEVERLY CHANG, MDAssistant Professor, Department of Anesthesiology, Perioperative and Pain Medicine, New York University Langone Medical Center, New York, NY
Purchase PDFPain occurs frequently in the intensive care setting even among nonprocedural patients. Pain in the critical care setting creates significant downstream burdens in the recovery and psychological health of patients. Moderate to severe pain is reported in a significant number of intensive care unit (ICU) patients without significant differences in pain scores between trauma/surgical patients and medical ICU patients. However comparatively, medical ICU patients were found to experience higher pain intensity. Many of these patients reported a lack of pain relief from their analgesics, and 90% described experiencing the highest levels of distress due to difficulty in communicating their pain. This review covers the physiology of pain, physiologic effects of pain, challenges of pain management in the ICU, preemptive analgesia, multimodal analgesia, and treatment of pain.
This review 4 figures, 12 tables, and 41 references.
Key words:Pain in the ICU, pain management, postoperative pain, preemptive analgesia, analgesic pain ladder, analgesia, opioids, patient-controlled analgesia
- 6
Acute Care: Pain Management
- CLAUDIA RANNIGER, MD, PHDDirector, Simulation Center, George Washington University CLASS Center, George Washington, University Hospital, Washington, DC
Purchase PDFPain is a chief complaint in more than 50% of emergency department (ED) visits. Injury accounts for approximately one-third of presentations associated with pain; other common diagnoses include neck and back pain, minor infections, abdominal pain, and headache. In the ED, pain is underdiagnosed and undertreated, and existing pain management practices in the ED are inconsistent. Inadequate pain management is common, and pain remains unchanged or worsens during the ED visit for more than 40% of patients. Patient satisfaction improves when expectations for pain control are met. This review covers the pathophysiology of pain and the practice of pain management. Figures show the approach to pain management in the ED, an example of a numerical and visual analog scale pain rating scale, field block of the pinna, ultrasound probe and hand position for ultrasound-guided regional anesthesia, regional anesthesia of the face, innervation of the hand and fingers, regional anesthesia of the median, radial and ulnar nerves, innervation of the foot, ultrasound-guided regional anesthesia of the posterior tibialis nerve, regional anesthesia of the sural nerve, and method of regional anesthesia of the dorsal foot.
This review contains 13 figures, 15 tables, and 71 references.
Key words: Acute pain, Pain management, Oligoanalgesia, Pain assessment, Inadequate pain management, Acute pain management, Pain management in the emergency department, Pain in the ED, Pain presentation
- 7
Opioid-induced Constipation: A Comprehensive Overview
By Trisha Patel, MD; Hamilton Chen, MD; John Michels, MD; Justin Hata, MD
Purchase PDFOpioid-induced Constipation: A Comprehensive Overview
- TRISHA PATEL, MD
- HAMILTON CHEN, MD
- JOHN MICHELS, MD
- JUSTIN HATA, MD
Purchase PDFIn the United States, 4.3 million adults are regularly taking opioid medications. Opioid-induced constipation (OIC) is underdiagnosed considering the prevalence of opioid use among Americans. This review is intended to clarify issues related to OIC. OIC is caused by opioids binding to specific receptors in the gastrointestinal system, resulting in various anatomic effects, including decreased gastric motility, increased sphincter tone, reduced intestinal secretions, and increased water absorption in the bowel. Various treatments include water and fiber consumption, laxatives, enemas, cessation of opioids, and central and peripheral opioid antagonists. OIC is treatable, but timely diagnosis and patient education are paramount for successful resolution.
Key words: chronic pain; constipation; mu, delta, and kappa receptors; myenteric plexus; opioid; opioid-induced constipation; opioid receptor antagonists; submucosal plexus
- 8
Paraplegia Following Epidural Steroid Injection
- DEVIN PECK, MDAssociate Partner, Austin Pain Associates, Austin, TX
Purchase PDFParaplegia following epidural steroid injection is, fortunately, an exceedingly rare complication. The differential diagnosis includes epidural hematoma, spinal cord injury/infarction, epidural abscess, and conversion disorder. Less likely diagnoses include worsening of underlying pathology, a new compressing lesion, or subarachnoid injection.
The artery of Adamkiewicz enters the spinal canal via the neural foramen and provides blood supply to the lower two thirds of the spinal cord via the anterior spinal artery. Avoidance of the artery during a transforaminal epidural steroid injection is facilitated by entering the inferior portion of the foramen.
Acute management of neurologic complications arising from an epidural steroid injection is facilitated by rapid identification of etiology. In the case of epidural hematoma, avoidance of permanent deficit is more likely when patients undergo prompt decompression. The role of intravenous steroids in acute spinal cord injury is controversial. Chronic management includes extensive rehabilitation, including physical and occupational therapy. Treatment of musculoskeletal nociceptive pain, such as due to shoulder overuse, and neuropathic pain is vital to optimize the patient’s participation in rehabilitative therapy.
Keywords: Epidural Steroid Injection; Complications; Spinal Cord Injury; Epidural Hematoma; Epidural Abscess; Artery of Adamkiewicz; Anterior Spinal Artery Syndrome; Particulate Steroid; Fluoroscopic Guidance
- 9
Patient-controlled Analgesia
- DEVIN PECK, MDAssociate Partner, Austin Pain Associates, Austin, TX
Purchase PDFPatient-controlled analgesia (PCA) is a method for controlling pain in which a patient is able to self-administer pain medications via activation of a mechanical distribution system. The key element of PCA is that the patient is in control of the analgesia. Respiratory depression is preceded by sedation, and a sedated patient is unable or unlikely to push the PCA button. The pump can also be programmed to have a continuous infusion rate, which is administered to the patient regardless of whether the patient activates a dose. Basal rates bypass the safety mechanism of patient control and can place the patient at higher risk for respiratory depression and sedation. Initiation of a PCA is often most appropriate in patients requiring frequent as-needed dosing of medications or when such dosing is anticipated. Patients’ acceptance of the technique is high, related in part to a sense of control over their own pain relief, a reduction in the delay for the receipt of pain medications, not receiving injections, and not having to interrupt or to bother nurses.
This review contains 2 tables and 20 references.
Key words: analgesic delivery systems, morphine metabolism, multimodal pain management, opioid pharmacology, opioid side effects, patient-controlled analgesia, patient safety, respiratory depression
- 10
Patient-controlled Epidural Analgesia/continuous Epidural Catheters
- DEVIN PECK, MDAssociate Partner, Austin Pain Associates, Austin, TX
Purchase PDFAlthough useful for management of many types of pain, the most common indication for epidural catheter placement is for management of labor pain. High lumbar and thoracic epidural catheter placement has gained increasing popularity in recent years for the management of postoperative pain. The technique is most commonly employed for procedures in which a thoracic or an extensive abdominal incision is anticipated. Absolute contraindications for epidural catheter placement include patient refusal, uncorrected hypovolemia, increased intracranial pressure, local infection at the planned site of insertion, and patient allergy to amide/ester local anesthetics. Relative contraindications include coagulopathy, an uncooperative patient, severe anatomic abnormalities of the spine, sepsis, and hypertension. The advantages include attenuation of the sympathetic response to surgical stimulation and pain; effects on the cardiovascular, respiratory, and gastrointestinal systems; thromboprotective effects; and possibly limitation of tumor spread. The risks of epidural catheter placement include epidural hematoma, infection, nerve or spinal cord injury, dural puncture, or respiratory or cardiovascular depression from a high block. Epidural opioids provide analgesia without causing motor or sympathetic blockade. Epidurally administered local anesthetics may result in decreased postoperative ileus, nausea, vomiting, and sedation, which can be associated with opioids. Local anesthetics and opioids act additively or synergistically and, when used together, can lead to a reduction in the dose of each drug.
This review contains 2 figures, 4 tables and 30 references.
- 11
Patient With a History of Active Substance Abuse Requesting Opioids for Chronic Pain
By Alan D. Kaye, MD, PhD; Martin J Carney, B.S; Mark R. Jones, M.D; Harold J. Campbell, B.S; Burton R. Beakley, M.D
Purchase PDFPatient With a History of Active Substance Abuse Requesting Opioids for Chronic Pain
- ALAN D. KAYE, MD, PHDProfessor, Program Director, and Chairman, Department of Anesthesiology, Professor, Department of Pharmacology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LAV
- MARTIN J CARNEY, B.S
- MARK R. JONES, M.D
- HAROLD J. CAMPBELL, B.S
- BURTON R. BEAKLEY, M.D
Purchase PDFHealth care providers face a considerable challenge when treating chronic pain patients with prescription opioid medications. Although indications exist for the use of these drugs, their addictive nature and street value render them high-risk targets for abuse, misuse, and diversion. All patients receiving opioids should, therefore, be screened for abuse potential before beginning opioid therapy, be required to sign an opioid agreement, and receive close monitoring throughout the course of their treatment. Patients who present with a history of active substance abuse are at higher risk for iatrogenic dependence and necessitate more frequent monitoring. Herein arise several ethical issues, such as the principle of justice, which mediates equitable treatment for all patients. This review discusses the disease underlying substance abuse and clinical manifestations thereof, as well as relevant pathophysiology, ethical issues, and guidelines for the safe treatment with opioids.
This review contains 3 tables and 43 references.
Key Words: addiction, ethics, opioids, safety, substance abuse
- 12
Vasovagal Response After Pain Procedures
By Erik Helander, MBBS; Ethan Phan, MPH; Ben Homra, MBBS Candidate; Alan D. Kaye, MD, PhD
Purchase PDFVasovagal Response After Pain Procedures
- ERIK HELANDER, MBBSResident, Department of Anesthesiology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LA
- ETHAN PHAN, MPHSenior Medical Student Louisiana State University School of Medicine, New Orleans, LA
- BEN HOMRA, MBBS CANDIDATEUniversity of Queensland SOM-Ochsner Clinical School, New Orleans, LA
- ALAN D. KAYE, MD, PHDProfessor, Program Director, and Chairman, Department of Anesthesiology, Professor, Department of Pharmacology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LAV
Purchase PDFVasovagal syncope (VVS) is a specific type of syncope associated with hypotension, bradycardia, and peripheral vasodilation usually lasting 20 seconds and rarely longer than several minutes. It is caused by emotional stress, fear, pain, instrumentation, blood phobia, heat, and orthostatic stress. When a triggering event is present, VVS is usually preceded by autonomic symptoms of pallor, sweating, nausea, and abdominal discomfort. It is a frequently cited immediate adverse event during pain procedures, with rates ranging between 0 and 8.7%. The use of moderate sedation has been shown to reduce the risk of first-time and repeat episodes of vasovagal reactions. However, early detection, simple conservative management, and a willingness to terminate the procedure have resulted in no serious adverse outcomes.
- 13
Strategies to Optimize the Efficacy of Regional Anesthesia
By Jeremy Pearl, MD; Pedram Aleshi, MD
Purchase PDFStrategies to Optimize the Efficacy of Regional Anesthesia
- JEREMY PEARL, MDClinical Instructor, Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA
- PEDRAM ALESHI, MDAssociate Professor, Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA
Purchase PDFThe mode of delivery of epidural solutions has progressed from clinician-delivered boluses, to automated continuous epidural infusions and the addition of patient-controlled epidural analgesia (PCEA), and now to programmed intermittent epidural boluses (PIEBs) in addition to PCEA. Currently, there is promising evidence for the use of combination PIEB and PCEA to minimize additional bolus requirements and reduce the amount of local anesthetic consumed, as well as improved patient satisfaction. There are few data regarding this mode of delivery in peripheral nerve catheters. The existing data in the peripheral nerve catheters do not show a clear advantage for the use of the programmed intermittent bolus (PIB) method. More studies are needed in various peripheral nerve/fascia plane blocks to answer this question. Studies looking at the median effective dose in 50% of patients of local anesthetics for labor epidurals (minimum local anesthetic concentration [MLAC]) have allowed the comparison of the relative potency of different local anesthetics. Even though the absolute numbers are not useful, we know that ropivacaine is only 60% as potent as bupivacaine for its analgesic potency and development of motor block, so it provides no advantage over bupivacaine for the labor epidural setting. MLAC studies have also allowed the study of adjuvants and their effect on labor analgesia. Fentanyl, epinephrine, and clonidine have been studied, showing significant local anesthetic–sparing effects. The risks and benefits of each adjuvant should be weighed for each patient, but fentanyl and epinephrine have an excellent benefit-to-risk ratio.
- 14
Sodium Channel Modulation in the Perception and Management of Pain
By Dennis Paul, Ph.D; Harry J. Gould III, M.D., Ph.D
Purchase PDFSodium Channel Modulation in the Perception and Management of Pain
- DENNIS PAUL, PH.DProfessor of Pharmacology and Experimental Therapeutics, Departments of Neurology, Pharmacology and Experimental Therapeutics, and Anesthesiology, Neuroscience Center of Excellence, Center of Excellence for Oral and Cranio¬facial Biology, Pain Mastery Center of Louisiana, Alcohol and Drug Abuse Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA
- HARRY J. GOULD III, M.D., PH.DProfessor of Neurology and Neuroscience, Departments of Neurology, Internal Medicine, Section of Physical Medicine and Rehabilitation, and Anesthesiology, Neuroscience Center of Excellence, Center of Excellence for Oral and Craniofacial Biology, Pain Mastery Center of Louisiana, Louisiana State University Health Sciences Center, New Orleans, LA
Purchase PDFSodium channels play a pivotal role in maintaining homeostasis and proper intracellular ion concentrations that are vital to all living cells for function and survival. In excitable tissues such as neurons and heart cells, sodium channels are responsible for establishing and maintaining the transmembrane electrochemical gradient, which is critical for intercellular communication and for the transduction, generation, modulation, and transmission of impulses that underlie normal physiologic function, the perception of stimuli, and the execution of appropriate behavioral responses. Injury and disease often affect changes in the channel density and subtype distribution present in cellular membranes, thereby upsetting the critical electrochemical balance necessary for normal functioning. When such changes affect the systems that process noxious stimulation and are acute and transient, they are beneficial. The pain that is perceived alerts us to current or impending injury and aids in vigilance during wound healing. But when the changes are persistent, the painful signals are no longer protective but, instead, become unrelenting and destructive to the quality of life. Because changes in sodium channel quantity and distribution play such a central role in the perception of pain and the development and maintenance of nociceptive chronicity, significant effort has been expended on discovering ways to affect sodium channel expression and function that might be effective in preventing or managing many painful conditions. The implications of modifying sodium channel expression and function for future therapeutic benefit are the subject of this review.
Key Words: Acute pain, chronic pain, sodium channels - 15
Iatrogenic Withdrawal Syndromes in Children: A Review of Sedative and Analgesic Weaning
By R. Blake Windsor, MD, FAAP; Jean Solodiuk, RN, PhD
Purchase PDFIatrogenic Withdrawal Syndromes in Children: A Review of Sedative and Analgesic Weaning
- R. BLAKE WINDSOR, MD, FAAPAssistant in Pain Medicine, Department of Anesthesia, Peri-Operative, and Pain Medicine, Adjunct in Emergency Medicine, Department of Medicine, Boston Children’s Hospital, Instructor in Anaesthesia, Harvard Medical School, Boston, MA
- JEAN SOLODIUK, RN, PHDResearch Associate, Department of Anesthesia, Peri-Operative, and Pain Medicine, Harvard Medical School, Boston, MA
Purchase PDFIatrogenic withdrawal syndromes develop in children exposed to prolonged sedative and analgesic medications. Signs of withdrawal include central nervous system irritability, gastrointestinal dysfunction, and autonomic dysfunction. The most important steps to the safe management of sedative and analgesic weaning in children are the early identification of the risk of withdrawal, use of a validated withdrawal assessment scale, use of nonpharmacologic interventions, and administration of medication for weaning, if indicated. This article reviews the physiologic mechanisms of opioid tolerance and withdrawal, validated pediatric withdrawal scales, and safe management of iatrogenic withdrawal syndromes. Figures illustrate cellular responses to acute and chronic exposure to opioids. A suggested algorithm for the safe and rapid weaning of sedative and analgesic medications, using the best available evidence, is discussed.
Key words: analgesic weaning, opioid tolerance, pediatric withdrawal, sedation weaning, weaning algorithm for children
- 16
Pharmacologic and Technological Innovations in Pain Medicine
By Anita Gupta, DO, PharmD; Hawa Abubakar, MD
Purchase PDFPharmacologic and Technological Innovations in Pain Medicine
- ANITA GUPTA, DO, PHARMD
- HAWA ABUBAKAR, MD
Purchase PDFThe experience of pain is subjective, and treatment modalities should aim at providing the greatest amount of pain relief while minimizing adverse effects. Pharmacologic and technological innovations are making this possible. By taking advantage of new manufacturing processes, the pharmaceutical industry is retooling old and effective drugs. SoluMatrix diclofenac uses nanotechnology to address the need for an effective nonsteroidal antiinflammatory drug at the lowest possible dose to minimize risks associated with cardiac, renal, and gastrointestinal side effects. Intravenous acetaminophen provides an additional alternative in multimodal analgesia in instances when the oral or rectal route of delivery is not desirable. Liposomal bupivacaine uses liposomal encapsulated, resulting in a local anesthetic with a prolonged duration of action that can be used effectively in the management of postoperative pain. With the recognition that opioid therapy still remains a mainstay in pain management, advances in science have allowed for the development of peripherally acting mu opioid receptor antagonists such as naloxegol, which minimize the bothersome side effect of opioid-induced constipation. In terms of interventional pain management, advances in radiofrequency ablation (RFA) technology have resulted in cooled RFA, which allows for the creation of larger spherical lesions, thereby alleviating pain by interfering with neurotransmission. Advances in stem cell research have led to the application of multipotent cells with the aim of treating the underlying disease process and thereby eliminating pain. Finally, pharmacogenetics testing and smart drugs provide an avenue via which issues surrounding how medication is consumed, determination of effectiveness, and ensuring compliance and adherence can be optimized.
Key words: Pain, Pharmacology, Medications, Technology, Innovation, Smart Pills, Personalized Medicine, Biotechnology, Device, Surgery, Multimodal
- 17
Ketamine Infusions for Complex Regional Pain Syndrome
- ROY K. ESAKI, MD, MS
Purchase PDFKetamine is an N-methyl-d-aspartate(NMDA) receptor antagonist that has been increasingly used in the management of treatment-resistant chronic pain conditions, particularly representing neuropathic involvement or central sensitization. Complex regional pain syndrome (CRPS) is a prototypical condition often treated with ketamine infusions. Although the analgesic benefits of ketamine as an opioid-sparing adjunct in the preoperative period have been well studied, the use of ketamine to mitigate chronic pain conditions remains largely anecdotal, composed largely of case reports and uncontrolled small studies. The limited evidence and published reports support the use of ketamine infusions as one aspect of a comprehensive, multimodal approach for CRPS. Although ketamine infusions are relatively safe when titrated appropriately, with minimal respiratory depression, side effects include sympathetic activation, unpleasant psychomimetic effects, lower urinary tract symptoms, and hepatic dysfunction.
- 18
Chronic Pelvic Pain: the Neuropathic Pain Basis
- STANLEY J. ANTOLAK JR, MD
Purchase PDFChronic pelvic pain (CPP) in both genders has been chiefly the province of surgical subspecialists. Morphologic end-organ processes have been studied for decades without significant advances in understanding the etiology of CPP or developing adequate therapeutic outcomes. The neurogenic basis of CPP has received little attention. Several peripheral nerves may be the source. The largest of these is a pudendal nerve and is the most important because it is a mixed nerve and affects sensory and motor symptoms in both the somatic and autonomic nervous systems. Nerve compression and stretch are the two most important etiologic factors.
Practitioners can diagnose these painful neuropathies by a careful symptom history and physical examination. The most important diagnostic tool is sensory examination of the pudendal territory using pinprick. Various neurophysiologic tests can confirm pudendal neuropathy. The smaller peripheral nerves affect CPP.
Because pudendal neuropathy is a tunnel syndrome related to cumulative, repetitive microtrauma, it can be treated accordingly. Treatment options include nerve protection, medications (analeptics, tricyclic amines), perineural infiltrations of local anesthetics with or without corticosteroids, and, in a significant minority, decompression of the pudendal nerves. The smaller nerves often respond to a program of postural correction and perineural anesthetic blockades. All patients require attention to central sensitization. Treatment success depends on the duration of symptoms, etiology, and severity of nerve damage. The last item can only be evaluated at surgery. Complete cures of CPP, treated using each modality, can be measured by validated symptom scores for as long as 13 years.
To progress in the diagnosis and treatment of CPP, interspecialty studies are needed that distinctly separate neurogenic from nonneurogenic CPP. To date, this has not been done. Thus, diagnostic, etiologic, and treatment conclusions are quite limited. CPP provides a rich foundation for clinical research for neurologists.
Key Words: abdominal cutaneous neuropathy, chronic pelvic pain, interstitial cystitis, irritable bowel syndrome, middle cluneal neuropathy, neurogenic pelvic pain, pudendal neuropathy, sexual dysfunction, thoracolumbar junction syndrome
- 19
Opioid-sparing Analgesics in Chronic Pain Management
By Maricela Schnur , MD, MBA; Michael Fitzsimons, MD; Fangfang Xing, MD
Purchase PDFOpioid-sparing Analgesics in Chronic Pain Management
- MARICELA SCHNUR , MD, MBAResident Physician, Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA
- MICHAEL FITZSIMONS, MDAssistant Professor, Harvard Medical School, Director, Division of Cardiac Anesthesia, Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA
- FANGFANG XING, MDResident Physician, Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA
Purchase PDFChronic pain impacts the lives of millions of people in significant medical and psychosocial ways. Pharmacologic treatments are steering away from chronic opioid therapy due to serious side effects, an epidemic of prescription opioid abuse, and a lack of clear long-term benefit. Therefore, nonopioid medications such as nonsteroidal antiinflammatory drugs, acetaminophen, tricyclic antidepressants, lidocaine patch, and anticonvulsants are important opioid-sparing or primary treatment options. Agents such as capsaicin, cannabis, botulinum toxin, and ketamine are less frequently prescribed adjuncts that are under active investigation to determine their roles in chronic pain therapy. Understanding the research can help the clinician determine the risks and benefits of these medications for their patients. In the future, dose and delivery optimization, combination therapy, elucidating the biology of pain, and developing novel agents will improve pharmacologic approaches to treatment.
- 20
Acute Postoperative Pain
- KELLY ZACH, MD Pain Medicine Fellow, Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, OR
- JULIO A. GONZALEZ-SOTOMAYOR, MDClinical Associate Professor, Director, Inpatient Adult Pain Service, Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, OR
Purchase PDFInadequate management of acute postoperative pain increases morbidity and mortality. Poorly controlled pain results in delayed hospital discharge and may lead to the development of chronic pain. Current evidence supports the implementation of a multimodal analgesic regimen, where different pharmacologic and nonpharmacologic interventions are used. The selection of the different components of this multimodal analgesic approach should consider their potential benefits and limitations, as well as the unique patient characteristics and the surgical procedure. It is the responsibility of the perioperative health care provider to formulate an optimal pain management strategy to ultimately enhance patient satisfaction and improve short- and long-term outcomes.
- 21
Unusual Drugs of Abuse in Chronic Pain Patients
By Alan D. Kaye, MD, PhD; Elyse Cornett, PhD; Charles Fox, MD; Shilpadevi Patil, MD; Harish Siddaiah, MD; Justin Creel; Matthew B. Novitch, BS
Purchase PDFUnusual Drugs of Abuse in Chronic Pain Patients
- ALAN D. KAYE, MD, PHDProfessor, Program Director, and Chairman, Department of Anesthesiology, Professor, Department of Pharmacology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LAV
- ELYSE CORNETT, PHDClinical Research Coordinator, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- CHARLES FOX, MDProfessor and Chairman, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- SHILPADEVI PATIL, MD
- HARISH SIDDAIAH, MD
- JUSTIN CREEL
- MATTHEW B. NOVITCH, BS
Purchase PDFChronic pain occurs in one third of the American population. Management of chronic pain is a growing area in health care; however, there is a dilemma for health care providers to treat the chronic pain of individuals who have known current or suspected drug abuse or addiction. Even if the individual is not addicted to opiates or prescription pain medications, it is possible to become addicted to a new substance. The National Institutes of Health considers drug addiction a neurophysiologic disease, and as of 2014, 24.6 million people in the United States abuse drugs. As more patients are seeking treatment for chronic pain, health care providers are seeing an increase in patients who have a history of drug abuse or addiction, and it is imperative that health care providers are aware of how best to care for these patients. This review discusses chronic pain and the drugs that are typically used to treat chronic pain, as well as drugs that have been reported to be abused in chronic pain patients. There are limited or no data available on the more recent designer drugs, such as bath salts, K2 (spice), and even common drugs of abuse, such as methylenedioxymethamphetamine (MDMA). More research should be conducted on what drugs are abused in chronic pain patients, especially nonopioid drugs such as stimulants. This information would help educate health care providers and create better pain treatment regimens for patients who abuse drugs.
Key words: chronic pain, drug abuse, marijuana, methamphetamine, opioids
- 22
Abuse-deterrent Formulations in the Treatment of Chronic Pain
By Sanford M Silverman, MD
Purchase PDFAbuse-deterrent Formulations in the Treatment of Chronic Pain
- SANFORD M SILVERMAN, MDCEO and Medical Director, Comprehensive Pain Medicine, Pompano Beach, FL, Affiliate Assistant Professor of Clinical Biomedical Science, Department of Integrated Medical Sciences, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL
Purchase PDFPrescription drug abuse is the fastest growing problem in the United States. According to the Centers for Disease Control and Prevention (CDC), enough opioid pain relievers were sold in 2010 to provide every adult in the United States with the equivalent of a typical dose of 5 mg of hydrocodone every 4 hours for 1 month. Many solutions have been proposed to address this problem, including treatment guidelines, political solutions (statutory changes), Risk Evaluation and Mitigation Strategy (REMS), and technological innovations. Many opioid products are manipulated (crushed, snorted, injected, etc.) to facilitate abuse. Since extended-release/long-acting (ER/LA) opioids contain a large amount of opioid contained in a single delivery system, they are a favorite target of abusers. In short, the goal of an abuser is to convert an ER/LA opioid into an immediate-release one. Abuse-deterrent formulations (ADFs) are intended to make manipulation more difficult or to make abuse of the manipulated product less attractive or less rewarding. One such technological solution is the development of ADFs for opioid pain medications. The Food and Drug Administration's (FDA) guidelines for industry released in 2015 establish the rationale and methodology for the development of ER/LA opioids that contain abuse-deterrent properties. The goal is to deterabuse, realizing that it is impossible to preventabuse.
Key words: abuse-deterrent formulations, abuse-deterrent opioids, CDC guidelines, FDA opioid guidelines, opioid abuse, opioid deaths, opioid diversion, opioid overdose, prescription drug abuse, REMS
- 23
Labor Pain Pathophysiology and Analgesic Options
By Ben Homra, MBBS Candidate; Alan D. Kaye, MD, PhD; Elyse Cornett, PhD; Justin Creel; Matthew B. Novitch, BS; Brendon M Hart, DO; Alexander D Allian, MS; Eric M Helander, MBBS
Purchase PDFLabor Pain Pathophysiology and Analgesic Options
- BEN HOMRA, MBBS CANDIDATEUniversity of Queensland SOM-Ochsner Clinical School, New Orleans, LA
- ALAN D. KAYE, MD, PHDProfessor, Program Director, and Chairman, Department of Anesthesiology, Professor, Department of Pharmacology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LAV
- ELYSE CORNETT, PHDClinical Research Coordinator, Department of Anesthesiology, LSU Health Sciences Center Shreveport, Shreveport, LA
- JUSTIN CREEL
- MATTHEW B. NOVITCH, BS
- BRENDON M HART, DO
- ALEXANDER D ALLIAN, MS
- ERIC M HELANDER, MBBS
Purchase PDFRegional neuraxial blocks, such as spinal and epidural anesthetics, are used for most women in the United States for labor pain. They are the most effective methods for preserving consciousness and the ability to participate in the second stage of labor. Regional neuraxial blocks may be augmented by combining spinal and epidural techniques, postlabor nonopioids and opioids, distraction therapy, and patient-controlled analgesia. In addition, several alternative analgesic methods have been recently recommended for labor pain without consensus on their respective efficacies, including yoga, exercise during pregnancy, acupuncture, hypnotism, hydrotherapy, and therapeutic massage. This review focuses on current updates and recent trends in labor pain management, the pathophysiology of labor pain, and the basic mechanisms supporting the efficacies of systemic, inhalation, neuraxial, and local analgesia during labor.
Key words: epidural, fentanyl, labor pain, local anesthetic, spinal analgesia
- 24
Continuous Peripheral Catheters/regional Anesthesia in Postoperative Pain Management
By David E. Hirsch, MD, MBA; Daneshvari R. Solanki, FRCA
Purchase PDFContinuous Peripheral Catheters/regional Anesthesia in Postoperative Pain Management
- DAVID E. HIRSCH, MD, MBA
- DANESHVARI R. SOLANKI, FRCA
Purchase PDFAs the number of surgical procedures has increased worldwide, so has the need for safe and effective postoperative pain control. Regional anesthesia, in which a provider uses local anesthesia and potentially other medications to provide anesthesia by focusing on blocking sensation at the surgical site, has become an important part of the postoperative pain regimen, thereby improving outcomes and comfort. Regional anesthesia plays a critical and significant role with regard to preemptive analgesia and multimodal anesthetic techniques. With the widespread use of ultrasonography and the introduction of peripheral nerve catheters, regional anesthesia has grown in its ability to provide longer-lasting, safe, and targeted pain control. Extended-relief lipid emulsion bupivacaine is another example of recent developments in drug technology that will further aid regional anesthesia delivery in the future.
This review contains 5 figures, 4 tables, and 23 references.
- 25
Pathophysiology of Pain: Why Does Chronic Pain Hurt? the Multiple Hit Theory
By Jack M Berger, MS, MD, PhD; Vladimir Zelman, MD, PhD
Purchase PDFPathophysiology of Pain: Why Does Chronic Pain Hurt? the Multiple Hit Theory
- JACK M BERGER, MS, MD, PHD
- VLADIMIR ZELMAN, MD, PHD
Purchase PDFAcute pain hurts and most often is the result of tissue injury. Chronic pain also hurts. Although those who suffer from chronic pain also tend to associate the onset with an injury, illness, or surgical procedure; the root cause is far more complex. Chronic pain most often does not follow dermatomal distributions associated with any injury, disease or surgical procedure. And more often than not, chronic pain sufferers also suffer from various forms of depression and/or anxiety. The process of central sensitization resulting from tissue injury has been elucidated, as has many of the molecular changes within the brain that perpetuate chronic pain. Genetics, epigenetics, environmental stressors, and emotional stressors all play roles to varying degrees in the development of the chronic pain state. This article explores how synaptic memories form in the brain as a result of both physical and emotional traumas (multiple hits) resulting in progression to chronic pain, because of failure of the brain’s descending modulatory mechanisms to prevent or control “the pain.”
This review contains 15 figures, and 178 references.
Key words: Epigenetics, memory, central sensitization, chronic pain
- 26
Antiepileptic and Antidepressant Drugs Used in the Treatment of Pain
By Lucia Daiana Voiculescu, MD
Purchase PDFAntiepileptic and Antidepressant Drugs Used in the Treatment of Pain
- LUCIA DAIANA VOICULESCU, MDAssociate Professor, Department of Anesthesiology, Perioperative Care and Pain Medicine, NYU School of Medicine, New York, NY
Purchase PDFAntiepileptics and antidepressants are two categories of drugs frequently used as adjuvant analgesics. They interfere with the pain pathways at different levels through complex and not always well-defined molecular mechanisms. Although only a few have been licensed for use in the treatment of certain types of pain, anticonvulsants and antidepressants are widely prescribed off-label for pain associated with a variety of conditions. Most solid data come from experience with their use for postherpetic neuralgia, pain associated with diabetic neuropathy, and fibromyalgia. Anticonvulsants and antidepressant drugs are frequently used as first-line therapy in the treatment of pain, especially neuropathic type.
Key words: antidepressant drugs, antiepileptic drugs, carbamazepine, gabapentinoids, neuropathic pain, off-label use, serotonin-norepinephrine reuptake inhibitors, serotonin syndrome, tricyclic antidepressants, use in specific populations
- 27
Physical Medicine and Rehabilitation: Modalities and Exercise
By Steven Calvino, MD; Jacob LaSalle, MD; David Fealey, MD
Purchase PDFPhysical Medicine and Rehabilitation: Modalities and Exercise
- STEVEN CALVINO, MDAssistant Professor, Department of Anesthesiology, Perioperative Care and Pain Medicine, New York University School of Medicine, New York, NY
- JACOB LASALLE, MDFellow Department of Anesthesiology, Perioperative Care and Pain Medicine, New York University School of Medicine, New York, NY
- DAVID FEALEY, MDResident Department of Anesthesiology, Perioperative Care and Pain Medicine, New York University School of Medicine, New York, NY
Purchase PDFFunction is the marker by which those in the medical profession treating patients with pain strive to improve. The profession of physical medicine and rehabilitation has, at its tenet, the goal of improving or even restoring physical function and therefore plays an integral role in the care of patients with pain. Physical modalities such as temperature therapy with both heat and cold; manual therapies, including manipulation, mobilization, massage, traction, and transcutaneous electrical nerve stimulation; and kinesio taping, are important adjunct therapies often employed in comprehensive rehabilitation programs. Although there is in general a lack of rigorous scientific evidence to support the use of these alternative modalities individually, their low-risk profiles, low cost, and ease of application combined with plenty of anecdotal evidence for their efficacy make them indispensable to the pain practitioner. Incorporating these adjunct therapies in conjunction with appropriate exercise protocols along with pharmacologic and interventional tools may place the pain patient at a distinct advantage, improving function and pain perception. In the following review, we introduce these concepts to allow guidance for incorporation into the treatment algorithm of common pain conditions.
This review contains 16 figures, 2 tables and 79 references
Key words: cryotherapy, exercise, manipulation, manual, massage, mobilization, temperature, traction, transcutaneous electrical nerve stimulation
- 28
Complementary, Alternative, and Integrative Medicine
- HELENE M. LANGEVIN, MDDirector, Osher Center for Integrative Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Purchase PDFComplementary and alternative medicine (CAM) refers to a group of diverse medical and health care systems, practices, and products that are not considered to be part of conventional or allopathic medicine. Common CAM practices (e.g., acupuncture, meditation, and therapeutic massage) are gradually becoming incorporated into conventional care in response to patients looking to alternative sources for information and advice about health matters and increased understanding of various CAM methods through evidence-based testing. However, although the claims of some methods are supported with academic research, well-founded concerns remain in many popularized CAM practices regarding the lack of evidence and placebo effects. It is thus imperative for physicians to be comfortable in discussing CAM-related topics with patients and be able to appropriately and informatively guide them in a way that harnesses potential benefits and avoids potential harm. In this review, the major CAM therapies in the United States are examined, including the settings in which they are being used, evidence base status, and efficacy of some of the most commonly used modalities.
This review contains 5 figures, 21 tables, and 123 references.
Keywords: Alternative medicine, complementary medicine, acupuncture, homeopathy, osteopathy, chiropractic, massage therapy, naturopathy
- 29
Sedation in the Intensive Care Setting
By William John Wallisch IV, MD; Ata Murat Kaynar, MD, MPH
Purchase PDFSedation in the Intensive Care Setting
- WILLIAM JOHN WALLISCH IV, MDAssistant Professor, Department of Anesthesiology, The University of Kansas, School of Medicine, Kansas City, KS
- ATA MURAT KAYNAR, MD, MPHProfessor, Departments of Critical Care Medicine and Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
Purchase PDFThe recent clinical trials on sedation and delirium in the ICU shifted the scales dramatically in the past 10 to 20 years and less sedation is now the accepted norm with titration goals. Now the art of sedation is in the hands of the clinicians to achieve a balance between alleviation of pain and anxiety while keeping patients calm, cooperative, and part of daily activities in the ICU. In this chapter we summarize the various assessment tools for optimal sedation in the ICU as well as the medications used to achieve sedation. However, the clinicians should not forget the nonpharmacologic approaches such as prevention of sleep interruption as part of a successful comprehensive sedation program in the ICU.
This review contains 3 tables, and 22 references.
Key Words: confusion assessment method, delirium, dexmedetomidine, etomidate, fentanyl, GABA, ketamine, propofol, Richmond agitation-sedation scale (RASS), sedation-agitation scale (SAS)
- 30
Pharmacologic Management for Cancer Pain
By Casey A. Murphy, MD; Randolph Roig, MD; John Faciane Jr., MD; Harry J. Gould, III, MD, PhD
Purchase PDFPharmacologic Management for Cancer Pain
- CASEY A. MURPHY, MDDepartments of Internal Medicine, Section of Physical Medicine and Rehabilitation, New Orleans Veterans Affairs Medical Center, New Orleans, LA
- RANDOLPH ROIG, MDAssociate Chief of Staff for Education and Designated Education Officer, U.S. Dept. of Veterans Affairs, Clinical Assistant Professor, New Orleans Veterans Affairs Medical Center, New Orleans, LA
- JOHN FACIANE JR., MDDepartments of Internal Medicine, Section of Physical Medicine and Rehabilitation, New Orleans Veterans Affairs Medical Center, New Orleans, LA
- HARRY J. GOULD, III, MD, PHDDepartments of Internal Medicine, Section of Physical Medicine and Rehabilitation, Neurology, Stanley S. Scott Cancer Center, Anesthesiology, Neuroscience Center of Excellence, Center of Excellence for Oral and Craniofacial Biology, and LSU Pain Medicine, Department of Neurology, Louisiana State University Health Sciences Center, New Orleans, LA
Purchase PDFChronic pain is a major factor that impairs functionality and compromises quality of life. Unfortunately, this type of pain is often under-treated due to lack of education about the use and range of effective non-pharmacologic modalities, about how to use and monitor pharmacologic modalities, and the fear about real and imagined adverse effects that are associated with its management. Cancer is diagnosed in approximately 40% of the population with up to 89% experiencing some form of pain in the later stages of the disease. Unfortunately, a significant portion of this population receives inadequate treatment for their pain. Here we provide a review of the evidence-base for determining the best approach for managing the pain of malignancy in the hope of providing a basic framework for the physician to better utilize the pharmacological options that comprise an important component of comprehensive pain care for the cancer patient.
This review contains 2 figures, 7 tables, and 106 references.
Keywords: Cancer pain, malignant pain, opioids, chronic pain, analgesic options, adjuvant options, cancer pharmacology, evidence-based pain treatment
- 31
Coronaviruses: Hcov, Sars-cov, Mers-cov, and COVID-19
- MICHAEL G. ISON, MD, MSCAssociate Professor, Divisions of Infectious Diseases & Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL
Purchase PDFCoronaviruses (CoVs) are a group of viral pathogens that infect mammals and birds. The presentation in humans is typically that of a mild upper respiratory tract infection, similar to the common cold. However, in recent years, dramatic attention has arisen for more lethal members of this viral family (e.g., severe acute respiratory syndrome [SARS-CoV], Middle East respiratory syndrome [MERS-CoV], and coronavirus disease 2019 [COVID-19]). The epidemiology, clinical presentation, diagnosis, and management of these viruses are discussed in this review. Importantly, new guideline tables from the Centers for Disease Control and Prevention, as well as the World Health Organization are provided at the conclusion of the review.
This review contains 12 tables, 3 figure and 48 references.
Keywords: Coronavirus, severe acute respiratory distress syndrome (SARS), Middle East respiratory syndrome (MERS), COVID-19, respiratory infection, antiviral, real-time polymerase chain reaction
- 32
Pain in the Intensive Care Setting
- BEVERLY CHANG, MDAssistant Professor, Department of Anesthesiology, Perioperative and Pain Medicine, New York University Langone Medical Center, New York, NY
- 33
Acute Care: Pain Management
Purchase PDFAcute Care: Pain Management
Purchase PDF - 34
Approach to the Patient With an Abnormal Drug Screen
By Magdalena Anitescu, MD, PhD; Jeffrey Hopcian, MD; John Henry Harrison, MD
Purchase PDFApproach to the Patient With an Abnormal Drug Screen
- MAGDALENA ANITESCU, MD, PHD
- JEFFREY HOPCIAN, MDAssistant Professor, Department of Anesthesia, Case Western Reserve University
- JOHN HENRY HARRISON, MDResident physician, University of Chicago Medicine, Department of Anesthesia and Critical Care
Purchase PDFUrine drug testing has become widely used in clinical practice as a measure to monitor patient adherence to treatment plans and assess the efficacy of the treatment prescribed. In many circumstances, the clinician is challenged with an abnormal urine drug screen either for a new patient or for a patient presumed to be compliant with the medication regimen; proper interpretation of the test result and a detailed history and physical examination during the visit are necessary to identify the cause of the abnormality and properly care for the patient.
- 35
Serotonin Syndrome
- RAVI MIRPURI, DOChief Resident, Department of Physical Medicine and Rehabilitation University of California, Irvine, Orange, CA
- DANIELLE PERRET KARIMI, MDAssociate Dean, Graduate Medical Education, Associate Physician, Department of Physical Medicine and Rehabilitation, University of California, Irvine, Orange, CA
- 1

- 1905-522-8526
- 1-855-647-6511
- For Individuals: [email protected]
For Residency: [email protected]
Copyright © 2025 Decker Medicine LLC. All rights reserved.
Trusted since 1980
